TWI777079B - Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof - Google Patents

Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof Download PDF

Info

Publication number
TWI777079B
TWI777079B TW108127452A TW108127452A TWI777079B TW I777079 B TWI777079 B TW I777079B TW 108127452 A TW108127452 A TW 108127452A TW 108127452 A TW108127452 A TW 108127452A TW I777079 B TWI777079 B TW I777079B
Authority
TW
Taiwan
Prior art keywords
compound
formula
acid
reaction
preparation
Prior art date
Application number
TW108127452A
Other languages
Chinese (zh)
Other versions
TW202019872A (en
Inventor
范江
陳清平
汪成濤
馮建川
Original Assignee
大陸商四川海思科製藥有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商四川海思科製藥有限公司 filed Critical 大陸商四川海思科製藥有限公司
Publication of TW202019872A publication Critical patent/TW202019872A/en
Application granted granted Critical
Publication of TWI777079B publication Critical patent/TWI777079B/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/19Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/38Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/12Formation of amino and carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/32Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08Acetic acid
    • C07C53/10Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/136Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/12Saturated polycyclic compounds
    • C07C61/125Saturated polycyclic compounds having a carboxyl group bound to a condensed ring system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

本發明提供了一種稠合三環γ-胺基酸衍生物的製備方法及中間體,如製備該稠合三環γ-胺基酸衍生物的中間體。所述稠合三環γ-胺基酸衍生物具有式(Ⅰ)所示的結構。所述製備方法原料易得、步驟簡單,整個合成技術都用結晶純化,沒有用到矽膠管柱層析或其他製備層析方法,適宜大規模工業化生產。

Figure 108127452-A0101-11-0001-1
The invention provides a preparation method and an intermediate of a fused tricyclic γ-amino acid derivative, such as an intermediate for preparing the fused tricyclic γ-amino acid derivative. The fused tricyclic γ-amino acid derivative has the structure represented by formula (I). The preparation method has easy-to-obtain raw materials and simple steps, and the entire synthesis technology is purified by crystallization without using silica gel column chromatography or other preparation chromatography methods, and is suitable for large-scale industrial production.
Figure 108127452-A0101-11-0001-1

Description

稠合三環γ-胺基酸衍生物的製備方法及其中間體Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof

本發明涉及醫藥領域,具體的說,本發明涉及一種稠合三環γ-胺基酸衍生物的製備方法及中間體。The invention relates to the field of medicine, in particular to a preparation method and an intermediate of a fused tricyclic γ-amino acid derivative.

電壓門控鈣離子通道由α1亞單位和輔助蛋白α2δ、β、γ亞基共同構成。α2δ蛋白可以調節鈣離子通道的密度及鈣離子通道電壓依賴性動力學 (Felix et al (199 7)J. Neuroscience 17: 6884- 6891; Klugbauer et al (1999) J. Neuroscience 19:684-691; Hobom et al (2000) Eur. J. Neuroscience 12: 1217-1226; and Qin et al (2002) Mol. Pharmacol. 62:485-496)。已經證實,對電壓依賴性鈣離子通道亞基α2δ表現出高親合力結合的化合物可有效治療疼痛,例如普瑞巴林和加巴噴丁。在哺乳動物中,α2δ蛋白有4個亞型,每個亞型均由不同的基因編碼。α2δ亞型1和亞型2與普瑞巴林表現出高親和力,而α2δ亞型3和亞型4無顯著的藥物結合力。Voltage-gated calcium channels are composed of α1 subunit and accessory protein α2δ, β, γ subunits. α2δ protein can modulate calcium channel density and calcium channel voltage-dependent kinetics (Felix et al (1997) J. Neuroscience 17: 6884-6891; Klugbauer et al (1999) J. Neuroscience 19:684-691; Hobom et al (2000) Eur. J. Neuroscience 12: 1217-1226; and Qin et al (2002) Mol. Pharmacol. 62: 485-496). Compounds that exhibit high affinity binding to the voltage-dependent calcium channel subunit α2δ have been shown to be effective in the treatment of pain, such as pregabalin and gabapentin. In mammals, there are four isoforms of α2δ proteins, each encoded by a different gene. α2δ isoforms 1 and 2 showed high affinity for pregabalin, while α2δ isoforms 3 and 4 showed no significant drug binding.

然而,對於加巴噴丁,其較大程度改善糖尿病周圍神經病變患者病痛的比例約為60%(Acta Neurol.Scand.101:359-371,2000),對於普瑞巴林,雖然其耐受性優於加巴噴丁,但其安全性更低,且有濫用或者使患者產生依賴的可能(Am J Health Syst Pharm. 2007;64(14):1475-1482)。However, for gabapentin, it improved the proportion of patients with diabetic peripheral neuropathy to a greater extent in about 60% (Acta Neurol. Scand. 101:359-371, 2000), for pregabalin, although it was better tolerated than gabapentin , but its safety is lower, and there is the possibility of abuse or dependence of patients (Am J Health Syst Pharm. 2007;64(14):1475-1482).

開發新的對電壓依賴性鈣離子通道亞基α2δ表現出高親合力結合的化合物仍然有很大的需求。There remains a great need to develop new compounds that exhibit high-affinity binding to the voltage-dependent calcium channel subunit α2δ.

本發明的一個目的在於提供一種稠合三環γ-胺基酸衍生物的製備方法。An object of the present invention is to provide a preparation method of a fused tricyclic γ-amino acid derivative.

本發明的另一目的在於提供用於製備稠合三環γ-胺基酸衍生物的中間體。Another object of the present invention is to provide intermediates for the preparation of fused tricyclic γ-amino acid derivatives.

為達上述目的,一方面,本發明提供了一種式(I)所示化合物的製備方法,其中,所述方法包括以式(III)化合物為原料進行反應製備得到,

Figure 02_image003
In order to achieve the above purpose, on the one hand, the present invention provides a method for preparing a compound represented by formula (I), wherein the method comprises using the compound of formula (III) as a raw material to prepare by reacting,
Figure 02_image003

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;R 2 is selected from a carboxyl protecting group or a C 1-6 alkyl group;

R11 選自C1-6 的烷基。R 11 is selected from C 1-6 alkyl groups.

根據本發明一些具體實施方案,其中,A選自苯磺酸。According to some specific embodiments of the present invention, wherein, A is selected from benzenesulfonic acid.

根據本發明一些具體實施方案,其中,R2 選自甲基、乙基、丙基、正丁基或第三丁基。According to some specific embodiments of the present invention, wherein, R 2 is selected from methyl, ethyl, propyl, n-butyl or tert-butyl.

根據本發明一些具體實施方案,其中,R2 選自第三丁基。According to some specific embodiments of the present invention, wherein, R 2 is selected from tert-butyl.

根據本發明一些具體實施方案,其中,R11 選自甲基、乙基、丙基或丁基。According to some specific embodiments of the present invention, wherein, R 11 is selected from methyl, ethyl, propyl or butyl.

根據本發明一些具體實施方案,其中,R11 選自甲基。According to some specific embodiments of the present invention, wherein, R 11 is selected from methyl.

其中可以理解的是,以式(III)化合物為原料進行反應製備得到式(I)化合物,可以先水解得到游離鹼,然後加入酸A脫去羧基保護基和成鹽。也可以是先將羧基保護基脫除,然後水解得到游離鹼,再與酸A成鹽。It can be understood that to prepare the compound of formula (I) by reacting the compound of formula (III) as a raw material, the free base can be obtained by hydrolysis first, and then acid A is added to remove the carboxyl protecting group and form a salt. Alternatively, the carboxyl protecting group can be removed first, and then hydrolyzed to obtain the free base, which is then formed into a salt with acid A.

本發明提供了一種式(I)所示化合物的製備方法,其中,所述方法包括以式(II)化合物為原料進行反應製備得到;

Figure 02_image001
(I)
Figure 02_image006
(II)The present invention provides a method for preparing a compound represented by formula (I), wherein the method comprises using the compound of formula (II) as a raw material to prepare by reaction;
Figure 02_image001
(I)
Figure 02_image006
(II)

R2 定義同前。R 2 is defined as before.

其中,式(I)所示化合物如下:

Figure 02_image001
(I) A定義同前。Wherein, the compound represented by formula (I) is as follows:
Figure 02_image001
(I) A is as defined above.

本發明提供了一種式(II)化合物的製備方法,以式(III)化合物為原料製備得到

Figure 02_image006
(II),
Figure 02_image008
(III)The present invention provides a method for preparing a compound of formula (II), which is prepared by using the compound of formula (III) as a raw material.
Figure 02_image006
(II),
Figure 02_image008
(III)

R1 、R2 的定義同前。The definitions of R 1 and R 2 are the same as above.

根據本發明一些具體實施方案,所述方法包括以式(III)化合物為原料先製備得到式(II)化合物,再以式(II)化合物為原料製備得到式(I)化合物,

Figure 02_image010
According to some specific embodiments of the present invention, the method comprises first preparing the compound of formula (II) by using the compound of formula (III) as a raw material, and then preparing the compound of formula (I) by using the compound of formula (II) as a raw material,
Figure 02_image010

A、R1 、R2 定義同上。A, R 1 and R 2 are as defined above.

根據本發明一些具體實施方案,其中,所述方法包括以式(III)化合物為原料先製備得到式(II)化合物,再以式(II)化合物為原料在酸A的存在下反應得到式(I)化合物。According to some specific embodiments of the present invention, wherein, the method comprises first preparing the compound of formula (II) by using the compound of formula (III) as a raw material, and then reacting the compound of formula (II) as a raw material in the presence of acid A to obtain the compound of formula ( I) Compounds.

本發明還提供了一種式(I)所示化合物的製備方法,其中,所述方法包括以式(II)化合物為原料進行反應製備式(I)所示化合物。The present invention also provides a method for preparing the compound represented by the formula (I), wherein the method comprises using the compound represented by the formula (II) as a raw material to react to prepare the compound represented by the formula (I).

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R2 選自羧基保護基或C1-6 的烷基。R 2 is selected from a carboxyl protecting group or a C 1-6 alkyl group.

根據本發明一些具體實施方案,其中,R2 選自第三丁基。According to some specific embodiments of the present invention, wherein, R 2 is selected from tert-butyl.

根據本發明一些具體實施方案,其中式(II)化合物與酸A反應製備得到式(I)所示化合物。According to some specific embodiments of the present invention, wherein the compound of formula (II) is reacted with acid A to prepare the compound represented by formula (I).

根據本發明一些具體實施方案,其中,酸A與式(II)化合物的莫耳比為1.1:1~5:1。According to some specific embodiments of the present invention, wherein, the molar ratio of acid A to the compound of formula (II) is 1.1:1~5:1.

根據本發明一些具體實施方案,酸A與式(II)化合物的莫耳比為1.1:1、1.2:1、1.3:1、1.5:1、2:1、3:1、4:1或者5:1。According to some embodiments of the invention, the molar ratio of acid A to compound of formula (II) is 1.1:1, 1.2:1, 1.3:1, 1.5:1, 2:1, 3:1, 4:1 or 5 :1.

根據本發明一些具體實施方案,其中,式(II)化合物和酸A的反應在室溫至回流均可以反應;According to some specific embodiments of the present invention, wherein, the reaction of the compound of formula (II) and acid A can be reacted at room temperature to reflux;

在一些具體實施方案中,反應溫度為70~90℃;In some specific embodiments, the reaction temperature is 70~90°C;

在一些具體實施例中,反應溫度為80~85℃。In some specific embodiments, the reaction temperature is 80-85°C.

在一些具體實施方案中,式(II)化合物與酸A反應的溶劑選自能與式(II)化合物相溶的任意溶劑,比如乙腈、二氯甲烷、乙醇、甲醇、乙酸異丙酯、水、甲苯、二氧六環及其組合溶劑。In some embodiments, the solvent in which the compound of formula (II) is reacted with acid A is selected from any solvent that is compatible with the compound of formula (II), such as acetonitrile, dichloromethane, ethanol, methanol, isopropyl acetate, water , toluene, dioxane and their combined solvents.

在一些實施方案中,溶劑選自水、乙腈、乙酸異丙酯、乙腈/水。In some embodiments, the solvent is selected from the group consisting of water, acetonitrile, isopropyl acetate, acetonitrile/water.

在一些實施方案中,溶劑選自乙腈/水(v/v=1:1)。In some embodiments, the solvent is selected from acetonitrile/water (v/v=1:1).

在一些實施方案中,式(II)化合物與酸A在能與式(II)化合物相溶的溶劑中反應得到式(I)所示化合物,所述溶劑選自乙腈、二氯甲烷、乙醇、甲醇、乙酸異丙酯、水、甲苯、二氧六環或其組合;進一步較佳的,酸A與式(II)化合物的莫耳比為1.1:1~5:1,在70-90℃下反應;更進一步較佳的,酸A與式(II)化合物的莫耳比為1.1:1,在80-85℃下反應;更進一步較佳的,所述溶劑選自乙腈、二氯甲烷或乙酸異丙酯。In some embodiments, the compound of formula (II) reacts with acid A in a solvent compatible with the compound of formula (II) to obtain the compound of formula (I), the solvent is selected from acetonitrile, dichloromethane, ethanol, Methanol, isopropyl acetate, water, toluene, dioxane or a combination thereof; further preferably, the molar ratio of acid A to the compound of formula (II) is 1.1:1~5:1, at 70-90°C more preferably, the molar ratio of acid A and the compound of formula (II) is 1.1:1, and the reaction is carried out at 80-85 °C; even more preferably, the solvent is selected from acetonitrile, dichloromethane or isopropyl acetate.

根據本發明一些具體實施方案,其中,所述方法還包括以式(III)化合物為原料製備式(II)所示化合物的步驟,

Figure 02_image012
According to some specific embodiments of the present invention, wherein, the method further comprises the step of preparing the compound represented by the formula (II) by using the compound of the formula (III) as a raw material,
Figure 02_image012

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;R 2 is selected from a carboxyl protecting group or a C 1-6 alkyl group;

R11 選自C1-6 的烷基。R 11 is selected from C 1-6 alkyl groups.

根據本發明一些具體實施方案,其中,R2 選自第三丁基。According to some specific embodiments of the present invention, wherein, R 2 is selected from tert-butyl.

根據本發明一些具體實施方案,其中,R11 選自甲基。According to some specific embodiments of the present invention, wherein, R 11 is selected from methyl.

本發明還提供了一種式(III)化合物的製備方法,其中,所述方法包括以式(IV)化合物為原料經過反應得到式(III)化合物的步驟,

Figure 02_image014
(IV)The present invention also provides a method for preparing a compound of formula (III), wherein the method includes the step of obtaining a compound of formula (III) by reacting the compound of formula (IV) as a raw material,
Figure 02_image014
(IV)

R2 定義同上。R 2 is as defined above.

其中,式(III)化合物如下:

Figure 02_image008
(III),Wherein, the compound of formula (III) is as follows:
Figure 02_image008
(III),

R1 定義同上。R 1 is as defined above.

根據本發明一些具體實施方案,一種式(III)化合物的製備方法,其中,(III)化合物的製備包括以式(IV)化合物和掌性酸為原料製備式(III)化合物。According to some specific embodiments of the present invention, a method for preparing the compound of formula (III), wherein the preparation of compound (III) comprises preparing the compound of formula (III) by using the compound of formula (IV) and a chiral acid as raw materials.

本發明所述掌性酸選自式(XI)化合物、R-α-甲基苯乙酸、(-)-二乙醯基-L-酒石酸、L-天冬胺酸或者右旋奎寧酸,

Figure 02_image016
(XI)The chiral acid of the present invention is selected from the compound of formula (XI), R-α-methylphenylacetic acid, (-)-diacetyl-L-tartaric acid, L-aspartic acid or d-quinic acid,
Figure 02_image016
(XI)

R1 選自H、羥基保護基或-C(=O)R11 ;R11 選自C1-6 的烷基;較佳R11 選自甲基。R 1 is selected from H, hydroxyl protecting group or -C(=O)R 11 ; R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

根據本發明的一些具體實施方案,一種式(III)化合物的製備方法,其中:

Figure 02_image018
。According to some specific embodiments of the present invention, a preparation method of a compound of formula (III), wherein:
Figure 02_image018
.

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;R 2 is selected from a carboxyl protecting group or a C 1-6 alkyl group;

R11 選自C1-6 的烷基。R 11 is selected from C 1-6 alkyl groups.

根據本發明一些具體實施方案,其中,R2 選自第三丁基。According to some specific embodiments of the present invention, wherein, R 2 is selected from tert-butyl.

根據本發明一些具體實施方案,其中,R11 選自甲基。According to some specific embodiments of the present invention, wherein, R 11 is selected from methyl.

根據本發明一些具體實施方案,掌性酸為(S)-(+)-O-乙醯基-L-扁桃酸或L-扁桃酸。According to some embodiments of the invention, the chiral acid is (S)-(+)-O-acetyl-L-mandelic acid or L-mandelic acid.

根據本發明一些具體實施方案,一種式(III)化合物的製備方法,其中,所述掌性酸和式(IV)化合物的莫耳比為0.5:1-1:1。According to some specific embodiments of the present invention, a preparation method of the compound of formula (III), wherein the molar ratio of the chiral acid and the compound of formula (IV) is 0.5:1-1:1.

根據本發明一些具體實施方案,一種式(III)化合物的製備方法,其中,掌性酸和式(IV)化合物在室溫到回流條件下反應。According to some specific embodiments of the present invention, a method for preparing a compound of formula (III), wherein a chiral acid and a compound of formula (IV) are reacted at room temperature to reflux conditions.

根據本發明一些具體實施方案,一種式(III)化合物的製備方法,其中,所述掌性酸選自式(XI)化合物、R-α-甲基苯乙酸、(-)-二乙醯基-L-酒石酸、L-天冬胺酸或者右旋奎寧酸;進一步較佳的,所述掌性酸和式(IV)化合物的莫耳比為0.5:1-1:1,在室溫到回流條件下反應。According to some specific embodiments of the present invention, a preparation method of the compound of formula (III), wherein the chiral acid is selected from the compound of formula (XI), R-α-methylphenylacetic acid, (-)-diacetyl group -L-tartaric acid, L-aspartic acid or d-quinic acid; further preferably, the molar ratio of the chiral acid and the compound of formula (IV) is 0.5:1-1:1, at room temperature react under reflux conditions.

根據本發明一些具體實施方案,其中,所述方法包括以式(IV)化合物為原料經過反應得到式(III)化合物,然後再對所述式(III)化合物進行重結晶(再結晶)。According to some specific embodiments of the present invention, wherein, the method comprises using the compound of formula (IV) as a raw material to obtain the compound of formula (III) through reaction, and then recrystallization (recrystallization) of the compound of formula (III).

本發明還提供了一種式(Ⅲ)所示化合物的精製方法,將式(III)化合物在重結晶溶劑中重結晶:

Figure 02_image008
(III)The present invention also provides a method for purifying the compound represented by formula (III), wherein the compound of formula (III) is recrystallized in a recrystallization solvent:
Figure 02_image008
(III)

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from carboxyl protecting group or C 1-6 alkyl group; preferably R 2 is selected from tert-butyl group;

R11 選自C1-6 的烷基;較佳R11 選自甲基。R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,將式(Ⅲ)化合物在重結晶溶劑中進行重結晶,所述重結晶溶劑為有機溶劑和/或水,較佳重結晶1-2次。According to some specific embodiments of the present invention, a method for purifying the compound represented by the formula (III), wherein the compound of the formula (III) is recrystallized in a recrystallization solvent, and the recrystallization solvent is an organic solvent and/or water, It is preferable to recrystallize 1-2 times.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,式(III)化合物與重結晶溶劑的質量體積比為1:10-1:30。According to some specific embodiments of the present invention, a method for purifying the compound represented by the formula (III), wherein the mass-volume ratio of the compound of the formula (III) to the recrystallization solvent is 1:10-1:30.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,所述有機溶劑選自異丙醇、乙腈或乙醇中的一種或多種的混合;According to some specific embodiments of the present invention, a method for purifying a compound represented by formula (III), wherein the organic solvent is selected from a mixture of one or more of isopropanol, acetonitrile or ethanol;

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,所述有機溶劑為異丙醇。According to some specific embodiments of the present invention, a method for purifying the compound represented by formula (III), wherein the organic solvent is isopropanol.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,重結晶溶劑為異丙醇和水。According to some specific embodiments of the present invention, a method for purifying the compound represented by formula (III), wherein the recrystallization solvents are isopropanol and water.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,異丙醇和水的體積比為(10-20):1。According to some specific embodiments of the present invention, a method for purifying the compound represented by formula (III), wherein the volume ratio of isopropanol and water is (10-20):1.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,異丙醇和水的體積比為10:1-30:1。According to some specific embodiments of the present invention, a method for purifying the compound represented by formula (III), wherein the volume ratio of isopropanol and water is 10:1-30:1.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,重結晶重複1-2次。According to some specific embodiments of the present invention, a method for purifying the compound represented by formula (III), wherein the recrystallization is repeated 1-2 times.

根據本發明一些具體實施方案,一種式(Ⅲ)所示化合物的精製方法,其中,式(III)化合物的製備包括首先以式(IV)化合物和掌性酸為原料製備式(III)化合物,然後再將式(III)化合物重結晶得到精製化合物。According to some specific embodiments of the present invention, a method for purifying the compound represented by the formula (III), wherein the preparation of the compound of the formula (III) comprises first preparing the compound of the formula (III) by using the compound of the formula (IV) and a chiral acid as raw materials, Then the compound of formula (III) is recrystallized to obtain a refined compound.

根據本發明一些具體實施方案,其中,掌性酸選自式(XI)化合物、R-α-甲基苯乙酸、(-)-二乙醯基-L-酒石酸、L-天冬胺酸或者右旋奎寧酸,

Figure 02_image016
(XI)According to some specific embodiments of the present invention, wherein, the chiral acid is selected from the compound of formula (XI), R-α-methylphenylacetic acid, (-)-diacetyl-L-tartaric acid, L-aspartic acid or D-quinic acid,
Figure 02_image016
(XI)

其中,R1 選自H、羥基保護基或-C(=O)R11Wherein, R 1 is selected from H, hydroxyl protecting group or -C(=O)R 11 ;

R11 選自C1-6 的烷基;R 11 is selected from C 1-6 alkyl;

在一些具體實施方案中,R11 選自甲基、乙基、丙基或丁基;In some specific embodiments, R 11 is selected from methyl, ethyl, propyl or butyl;

在一些具體實施方案中,R11 選自甲基。In some specific embodiments, R 11 is selected from methyl.

根據本發明一些具體實施方案,其中,掌性酸選自式(XI)化合物,

Figure 02_image016
(XI)According to some specific embodiments of the present invention, wherein the chiral acid is selected from compounds of formula (XI),
Figure 02_image016
(XI)

其中,R1 選自H或-C(=O)R11wherein, R 1 is selected from H or -C(=O)R 11 ;

R11 選自甲基。R 11 is selected from methyl.

根據本發明一些具體實施方案,掌性酸為(S)-(+)-O-乙醯基-L-扁桃酸或L-扁桃酸。According to some embodiments of the invention, the chiral acid is (S)-(+)-O-acetyl-L-mandelic acid or L-mandelic acid.

根據本發明一些具體實施方案,其中,式(XI)化合物和式(IV)化合物的莫耳比為0.5:1~1:1。According to some specific embodiments of the present invention, the molar ratio of the compound of formula (XI) to the compound of formula (IV) is 0.5:1 to 1:1.

在一些具體實施方案中,式(XI)化合物和式(IV)化合物的莫耳比為0.5:1~0.8:1。In some specific embodiments, the molar ratio of the compound of formula (XI) to the compound of formula (IV) is from 0.5:1 to 0.8:1.

根據本發明一些具體實施方案,其中,式(IV)化合物和式(XI)化合物在室溫至回流條件下進行反應;According to some specific embodiments of the present invention, wherein, the compound of formula (IV) and the compound of formula (XI) are reacted at room temperature to reflux conditions;

根據本發明一些具體實施方案,式(XI)化合物和式(IV)化合物在80~90℃下反應。According to some specific embodiments of the present invention, the compound of formula (XI) and the compound of formula (IV) are reacted at 80-90°C.

根據本發明一些具體實施方案,其中,所述方法包括以式(IV)化合物為原料經過反應得到式(III)化合物的粗品,然後再利用重結晶溶劑,如有機溶劑和/或水對所述粗品進行重結晶。According to some specific embodiments of the present invention, wherein, the method comprises using the compound of formula (IV) as a raw material to obtain a crude product of the compound of formula (III) through a reaction, and then using a recrystallization solvent, such as an organic solvent and/or water for the described The crude product was recrystallized.

根據本發明一些具體實施方案,其中,所述有機溶劑選自異丙醇、乙腈、乙醇和水中的一種或多種的混合;較佳為異丙醇和水的混合,或者乙醇和水的混合。According to some specific embodiments of the present invention, wherein, the organic solvent is selected from a mixture of one or more of isopropanol, acetonitrile, ethanol and water; preferably a mixture of isopropanol and water, or a mixture of ethanol and water.

根據本發明一些具體實施方案,其中,異丙醇和水的體積比為(10-30):1。According to some specific embodiments of the present invention, the volume ratio of isopropanol and water is (10-30):1.

根據本發明一些具體實施方案,其中,異丙醇和水的體積比為(10-20):1。According to some specific embodiments of the present invention, the volume ratio of isopropanol and water is (10-20):1.

根據本發明一些具體實施方案,其中,乙醇和水的體積比為(10-30):1。According to some specific embodiments of the present invention, the volume ratio of ethanol and water is (10-30):1.

在一些實施方式中,乙醇和水的體積比為(10-20):1。In some embodiments, the volume ratio of ethanol to water is (10-20):1.

根據本發明一些具體實施方案,其中,式(III)化合物與重結晶溶劑的質量體積比為1:10-1:30;在一些實施方案中,質量體積比為1:10-1:20。According to some specific embodiments of the present invention, the mass-volume ratio of the compound of formula (III) to the recrystallization solvent is 1:10-1:30; in some embodiments, the mass-volume ratio is 1:10-1:20.

根據本發明一些具體實施方案,其中,重結晶溶劑為異丙醇和水,異丙醇和水的體積比為10:1~30:1。According to some specific embodiments of the present invention, wherein, the recrystallization solvent is isopropanol and water, and the volume ratio of isopropanol and water is 10:1 to 30:1.

根據本發明一些具體實施方案,其中,所述重結晶的步驟包括式(III)粗品溶解於重結晶溶劑中,攪拌反應0.5~1小時後,析晶。According to some specific embodiments of the present invention, wherein, the step of recrystallization comprises dissolving the crude product of formula (III) in a recrystallization solvent, and crystallization after stirring and reacting for 0.5 to 1 hour.

根據本發明一些具體實施方案,其中,重結晶重複1-2次。According to some specific embodiments of the present invention, wherein, the recrystallization is repeated 1-2 times.

其中可以理解的是,所述的重複,是在首次的基礎上進行重複,譬如,重複1次,則是重結晶2次;重複2次,則相當於重結晶3次。It can be understood that the repetition is repeated on the basis of the first time. For example, if the repetition is repeated once, it is recrystallized twice; if the repetition is repeated twice, it is equivalent to the recrystallization three times.

根據本發明一些具體實施方案,其中,所述方法還包括以式(V)化合物為原料製備式(IV)化合物的步驟,

Figure 02_image023
According to some specific embodiments of the present invention, wherein, the method further comprises the step of preparing the compound of formula (IV) by using the compound of formula (V) as a raw material,
Figure 02_image023

R2 定義同上。R 2 is as defined above.

根據本發明一些具體實施方案,其中,式(IV)化合物的製備包括:以式(V)化合物為原料在催化劑和還原劑的存在下,在0-40℃下製備式(IV)化合物。According to some specific embodiments of the present invention, wherein, the preparation of the compound of formula (IV) comprises: preparing the compound of formula (IV) at 0-40° C. using the compound of formula (V) as a raw material in the presence of a catalyst and a reducing agent.

在某些實施方案中,化合物(V)發生還原反應生成化合物(IV)的催化劑/還原劑可以選自雷尼鎳/水合肼、氯化鎳六水合物/硼氫化鈉、鐵粉/氯化銨、10%鈀碳/三乙基矽、雷尼鎳/氫氣、10%鈀碳/氫氣或者鋅粉/乙酸。In certain embodiments, the catalyst/reducing agent for the reduction reaction of compound (V) to form compound (IV) can be selected from Raney nickel/hydrazine hydrate, nickel chloride hexahydrate/sodium borohydride, iron powder/chloride Ammonium, 10% palladium carbon/triethyl silicon, Raney nickel/hydrogen, 10% palladium carbon/hydrogen, or zinc dust/acetic acid.

在某些實施方案中,催化劑/還原劑選自氯化鎳六水合物/硼氫化鈉或者10%鈀碳/氫氣。In certain embodiments, the catalyst/reducing agent is selected from nickel chloride hexahydrate/sodium borohydride or 10% palladium on carbon/hydrogen.

在某些實施方案中,還原條件是:0-40°C,醇溶劑中,氯化鎳六水合物作催化劑,硼氫化鈉作還原劑;或者,0-40°C,醇溶劑中,鈀碳作催化劑,氫氣作還原劑。在某些實施方案中,醇溶劑為甲醇或者乙醇。In certain embodiments, the reduction conditions are: 0-40°C, in an alcohol solvent, nickel chloride hexahydrate as a catalyst, and sodium borohydride as a reducing agent; or, 0-40°C, in an alcohol solvent, palladium Carbon is used as catalyst and hydrogen is used as reducing agent. In certain embodiments, the alcoholic solvent is methanol or ethanol.

在某些實施方案中,還原反應的溫度為20°C ~30°C。In certain embodiments, the temperature of the reduction reaction is between 20°C and 30°C.

在某些實施方案中,式(V)化合物與催化劑莫耳比為1:1~10:1,在某些實施方案中,莫耳比為2:1~5:1,在某些實施方案中,莫耳比為2:1、3:1、4:1、5:1。In certain embodiments, the molar ratio of the compound of formula (V) to catalyst is 1:1 to 10:1, in certain embodiments, the molar ratio is 2:1 to 5:1, in certain embodiments , the molar ratios are 2:1, 3:1, 4:1, 5:1.

在某些實施方案中,式(V)化合物與還原劑莫耳比為1:2~1:10,在某些實施方案中,莫耳比為1:2.5~1:5,在某些實施方案中,莫耳比為1:2.5、1:3、1:4、1:5。In certain embodiments, the molar ratio of the compound of formula (V) to the reducing agent is 1:2 to 1:10, in certain embodiments, the molar ratio is 1:2.5 to 1:5, in certain embodiments In the scheme, the molar ratios are 1:2.5, 1:3, 1:4, 1:5.

在某些實施方案中,式(V)化合物:催化劑:還原劑的莫耳比為1:0.2:2.5-1:0.5:5。在某些實施方案中,莫耳比為1:0.2:2.5、1:0.2:5、1:0.2:4、1:0.5:5,在某些實施方案中,莫耳比為1:0.2:4。In certain embodiments, the compound of formula (V):catalyst:reducing agent has a molar ratio of 1:0.2:2.5 to 1:0.5:5. In certain embodiments, the molar ratio is 1:0.2:2.5, 1:0.2:5, 1:0.2:4, 1:0.5:5, and in certain embodiments, the molar ratio is 1:0.2: 4.

根據本發明一些具體實施方案,其中,所述方法還包括式(V)化合物的製備:包括以式(VI)化合物為原料製備式(V)化合物,

Figure 02_image025
According to some specific embodiments of the present invention, wherein, the method further comprises the preparation of the compound of formula (V): comprising preparing the compound of formula (V) by using the compound of formula (VI) as a raw material,
Figure 02_image025

R2 定義同上。R 2 is as defined above.

根據本發明一些具體實施方案,其中,在鹼存在下,化合物(VI)與硝基甲烷發生加成反應生成化合物(V);作為選擇,可以有溶劑存在,所述溶劑選自二甲亞碸、N,N-二甲基甲醯胺、N-甲基吡咯烷酮或四氫呋喃。According to some specific embodiments of the present invention, wherein, in the presence of a base, compound (VI) undergoes an addition reaction with nitromethane to form compound (V); alternatively, a solvent may exist, and the solvent is selected from dimethyl sulfite , N,N-dimethylformamide, N-methylpyrrolidone or tetrahydrofuran.

根據本發明一些具體實施方案,其中,式(V)化合物的製備包括:式(VI)化合物和硝基甲烷在鹼存在下,無其他溶劑環境中反應製備式(V)化合物。According to some specific embodiments of the present invention, wherein, the preparation of the compound of formula (V) comprises: the compound of formula (VI) and nitromethane are reacted in the presence of a base without other solvent environment to prepare the compound of formula (V).

根據本發明一些具體實施方案,其中,鹼選自碳酸銫、第三丁醇鉀或者1,8-二氮雜二環十一碳-7-烯。According to some specific embodiments of the present invention, wherein, the base is selected from cesium carbonate, potassium tert-butoxide or 1,8-diazabicycloundec-7-ene.

根據本發明一些具體實施方案,其中,加成反應的溫度為60°C~回流。According to some specific embodiments of the present invention, wherein, the temperature of addition reaction is 60 ℃~reflux.

根據本發明一些具體實施方案,其中,加成反應的溫度為80°C ~100°C。According to some specific embodiments of the present invention, wherein, the temperature of addition reaction is 80 ℃~100 ℃.

根據本發明一些具體實施方案,其中,加成反應的溫度為85°C ~90°C。According to some specific embodiments of the present invention, wherein, the temperature of addition reaction is 85 ℃~90 ℃.

根據本發明一些具體實施方案,其中,加成反應的溫度為80°C ~85°C。According to some specific embodiments of the present invention, wherein, the temperature of addition reaction is 80 ℃~85 ℃.

根據本發明一些具體實施方案,其中,在鹼存在下,化合物(VI)與硝基甲烷發生加成反應生成化合物(V);作為選擇,可以有溶劑存在,所述溶劑選自二甲亞碸或N,N-二甲基甲醯胺。According to some specific embodiments of the present invention, wherein, in the presence of a base, compound (VI) undergoes an addition reaction with nitromethane to form compound (V); alternatively, a solvent may exist, and the solvent is selected from dimethyl sulfite Or N,N-dimethylformamide.

根據本發明一些具體實施方案,其中,化合物(V)與硝基甲烷反應的投料莫耳比為1:2.5~1:10, 1:3~1:9, 1:3~1:8, 1:3~1:7, 1:3~1:6, 1:3~1:5或1:3~1:4。According to some specific embodiments of the present invention, wherein, the molar ratio of compound (V) reacting with nitromethane is 1:2.5~1:10, 1:3~1:9, 1:3~1:8, 1 :3~1:7, 1:3~1:6, 1:3~1:5 or 1:3~1:4.

在某些實施方案中,化合物(V)與硝基甲烷反應的投料莫耳比為1:2.5、1:3、1:4、1:5、1:6、1:7、1:8、1:9或1:10。In certain embodiments, the molar ratio of compound (V) reacting with nitromethane is 1:2.5, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9 or 1:10.

根據本發明一些具體實施方案,其中,所述方法還包括式(VI)化合物的製備:包括以式(VII)化合物為原料製備式(VI)化合物,

Figure 02_image027
。According to some specific embodiments of the present invention, wherein, the method further comprises the preparation of the compound of formula (VI): comprising preparing the compound of formula (VI) by using the compound of formula (VII) as a raw material,
Figure 02_image027
.

根據本發明一些具體實施方案,其中,式(VI)化合物的製備包括:在鹼存在下,式(VII)化合物與選自二甲氧基膦醯基乙酸第三丁酯、二乙氧基磷醯基乙酸第三丁酯、溴乙酸第三丁酯、氯乙酸第三丁酯或者乙醯乙酸第三丁酯中任意一種化合物發生反應生成式(VI)化合物。According to some specific embodiments of the present invention, wherein, the preparation of the compound of formula (VI) comprises: in the presence of a base, the compound of formula (VII) is combined with tertiary butyl dimethoxyphosphonoacetate, diethoxyphosphorus A compound of formula (VI) is formed by reacting any one of the compounds among tertiary butyl acyl acetate, 3 butyl bromoacetate, 3 butyl chloroacetate or 3 butyl acetoacetate.

根據本發明一些具體實施方案,其中,製備(VI)化合物所用的鹼選自第三丁醇鉀、1,8-二氮雜二環十一碳-7-烯、二異丙基胺基鋰、碳酸鉀或者氫化鋰。According to some specific embodiments of the present invention, wherein, the base used in the preparation of compound (VI) is selected from potassium tert-butoxide, 1,8-diazabicycloundec-7-ene, lithium diisopropylamide , potassium carbonate or lithium hydride.

根據本發明一些具體實施方案,其中,製備(VI)化合物所用的鹼選自第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯。According to some specific embodiments of the present invention, wherein, the base used in the preparation of compound (VI) is selected from potassium tertiary butoxide or 1,8-diazabicycloundec-7-ene.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為10°C~40°C。According to some specific embodiments of the present invention, wherein, the temperature of the reaction of the compound of formula (VII) with tert-butyl dimethoxyphosphonoacetate is 10°C to 40°C.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為10°C ~30°C。According to some specific embodiments of the present invention, wherein, the temperature of the reaction of the compound of formula (VII) with tert-butyl dimethoxyphosphonoacetate is 10°C to 30°C.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為10°C ~15°C。According to some specific embodiments of the present invention, wherein, the temperature of the reaction of the compound of formula (VII) with tert-butyl dimethoxyphosphonoacetate is 10°C to 15°C.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為20°C ~40°C。According to some specific embodiments of the present invention, wherein, the temperature of the reaction of the compound of formula (VII) with tert-butyl dimethoxyphosphonoacetate is 20°C to 40°C.

根據本發明一些具體實施方案,其中,式(VII)化合物與二甲氧基膦醯基乙酸第三丁酯反應的溫度為30°C ~40°C。According to some specific embodiments of the present invention, wherein, the temperature of the reaction of the compound of formula (VII) with tert-butyl dimethoxyphosphonoacetate is 30°C to 40°C.

根據本發明一些具體實施方案,其中,二甲氧基膦醯基乙酸第三丁酯可以替換為二乙氧基磷醯基乙酸第三丁酯、溴乙酸第三丁酯、氯乙酸第三丁酯或者乙醯乙酸第三丁酯。According to some specific embodiments of the present invention, wherein, tertiary butyl dimethoxyphosphoronyl acetate can be replaced with tertiary butyl diethoxy phosphoronyl acetate, tertiary butyl bromoacetate, tertiary butyl chloroacetate ester or 3-butyl acetoacetate.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯的莫耳比為1:1~1:10。According to some specific embodiments of the present invention, wherein, the molar ratio of compound (VII) to tert-butyl dimethoxyphosphonoacetate is 1:1 to 1:10.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯的莫耳比為1:1.1~1:5。According to some specific embodiments of the present invention, wherein, the molar ratio of compound (VII) to tert-butyl dimethoxyphosphoronoacetate is 1:1.1~1:5.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯的莫耳比為1:1.1~1:2。According to some specific embodiments of the present invention, wherein, the molar ratio of compound (VII) to tert-butyl dimethoxyphosphonoacetate is 1:1.1~1:2.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯的莫耳比為1:1.1~1:1.5。According to some specific embodiments of the present invention, wherein, the molar ratio of compound (VII) to tert-butyl dimethoxyphosphonoacetate is 1:1.1~1:1.5.

根據本發明一些具體實施方案,其中,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯在溶劑中進行反應。在某些實施方案中,溶劑選自四氫呋喃。According to some specific embodiments of the present invention, wherein, compound (VII) is reacted with tert-butyl dimethoxyphosphonoacetate in a solvent. In certain embodiments, the solvent is selected from tetrahydrofuran.

本發明還提供了一種式(VII)所示化合物的製備方法,其中,所述方法包括以式(VIII)化合物為原料製備式(VII)化合物,

Figure 02_image029
The present invention also provides a method for preparing a compound represented by formula (VII), wherein the method comprises using the compound of formula (VIII) as a raw material to prepare the compound of formula (VII),
Figure 02_image029

R3 和R4 各自分別獨立的選自C1-6 的烷基;R 3 and R 4 are each independently selected from C 1-6 alkyl groups;

可選的,R3 和R4 和與其連接的碳原子共同形成環。Optionally, R3 and R4 together with the carbon atom to which they are attached form a ring.

根據本發明一些具體實施方案,其中,R3 和R4 各自分別獨立選自甲基、乙基或者異丙基。According to some specific embodiments of the present invention, wherein, R 3 and R 4 are each independently selected from methyl, ethyl or isopropyl.

根據本發明一些具體實施方案,其中, R3 和R4 與所連接的氮原子形成呱啶環或者四氫吡咯環。According to some specific embodiments of the present invention, wherein, R 3 and R 4 and the attached nitrogen atom form a pyridine ring or a tetrahydropyrrole ring.

根據本發明一些具體實施方案,其中,R3 和R4 與所連接的氮原子形成四氫吡咯環。According to some specific embodiments of the present invention, wherein, R 3 and R 4 form a tetrahydropyrrole ring with the nitrogen atom to which they are attached.

根據本發明一些具體實施方案,其中,所述方法包括以式(VIII)化合物和酸酐在吡啶類的鹼存在下反應製備式(VII)化合物。According to some specific embodiments of the present invention, wherein the method comprises reacting a compound of formula (VIII) and an acid anhydride in the presence of a pyridine base to prepare a compound of formula (VII).

本發明所述酸酐選自三氟甲烷磺酸酐或對甲苯磺酸酐。The acid anhydride of the present invention is selected from trifluoromethanesulfonic anhydride or p-toluenesulfonic anhydride.

本發明所述吡啶類的鹼是指包含吡啶結構的鹼,比如2,4,6-三甲基吡啶、2,6-二甲基吡啶或者吡啶。The pyridine bases in the present invention refer to bases containing a pyridine structure, such as 2,4,6-collidine, 2,6-lutidine or pyridine.

根據本發明一些具體實施方案,其中,所述方法包括以式(VIII)化合物和三氟甲烷磺酸酐和吡啶類的鹼存在下反應製備式(VII)化合物。According to some specific embodiments of the present invention, wherein, the method comprises preparing the compound of formula (VII) by reacting the compound of formula (VIII) with trifluoromethanesulfonic anhydride and a base such as pyridine.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐反應結束後,還包括用鹼對反應液進行鹼處理的步驟。According to some specific embodiments of the present invention, wherein, after the reaction of the compound of formula (VIII) with the pyridine-based base and trifluoromethanesulfonic anhydride is completed, the step of alkali-treating the reaction solution with a base is further included.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐反應結束後,用鹼對反應液進行鹼處理,調節pH值為鹼性;在某些實施方案中,調至pH值為10-11。According to some specific embodiments of the present invention, wherein, after the reaction between the compound of formula (VIII) and the pyridine base and trifluoromethanesulfonic anhydride is completed, the reaction solution is subjected to alkali treatment with a base to adjust the pH value to be basic; in some implementations In the protocol, the pH was adjusted to 10-11.

在某些實施方案中,鹼可以選自無機鹼。In certain embodiments, the base may be selected from inorganic bases.

在某些實施方案中,無機鹼可以選自氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉、氟化銫或者碳酸銫;pH至鹼性可以選自pH值為8-14、8-11、9-11或者10-11。In certain embodiments, the inorganic base can be selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, sodium bicarbonate, cesium fluoride, or cesium carbonate; pH to basic can be selected from pH 8- 14, 8-11, 9-11 or 10-11.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐反應結束後,用鹼對反應液進行鹼處理後,繼續反應至中間體反應完畢,還包括用酸對反應液進行酸化處理的步驟。According to some specific embodiments of the present invention, wherein, after the reaction between the compound of formula (VIII) and the pyridine base and trifluoromethanesulfonic anhydride is completed, the reaction solution is subjected to alkali treatment with a base, and the reaction is continued until the reaction of the intermediate is completed. The step of acidifying the reaction solution with an acid.

本發明所述酸化處理指用酸調節反應液pH為酸性。The acidification treatment in the present invention refers to adjusting the pH of the reaction solution to be acidic with an acid.

根據本發明一些具體實施方案,所述酸化處理指用無機酸調節反應液為酸性。According to some specific embodiments of the present invention, the acidification treatment refers to adjusting the reaction liquid to be acidic with an inorganic acid.

根據本發明一些具體實施方案,所述酸化處理指調節反應液pH為1-4。According to some specific embodiments of the present invention, the acidification treatment refers to adjusting the pH of the reaction solution to 1-4.

根據本發明一些具體實施方案,所述無機酸為硫酸、鹽酸、磷酸或硝酸。According to some specific embodiments of the present invention, the inorganic acid is sulfuric acid, hydrochloric acid, phosphoric acid or nitric acid.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐反應結束後,用鹼對反應液進行鹼處理後,繼續反應至中間體反應完畢,還包括用酸對反應液進行酸化,pH調節為1-2;According to some specific embodiments of the present invention, wherein, after the reaction between the compound of formula (VIII) and the pyridine base and trifluoromethanesulfonic anhydride is completed, the reaction solution is subjected to alkali treatment with a base, and the reaction is continued until the reaction of the intermediate is completed. The reaction solution is acidified with acid, and the pH is adjusted to 1-2;

根據本發明一些具體實施方案,其中,所述的酸為無機酸;在某些實施方案中為硫酸、鹽酸、磷酸和硝酸中的一種或多種的混合。According to some specific embodiments of the present invention, wherein, the acid is an inorganic acid; in some embodiments, it is a mixture of one or more of sulfuric acid, hydrochloric acid, phosphoric acid and nitric acid.

根據本發明一些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐是在室溫至回流下進行反應。在某些實施方案中,在回流下進行反應。According to some specific embodiments of the present invention, wherein, the compound of formula (VIII) and the base of pyridine, trifluoromethanesulfonic anhydride are reacted at room temperature to reflux. In certain embodiments, the reaction is carried out under reflux.

在某些實施方案中,式(VII)所示的化合物的製備方法包括以下步驟:In certain embodiments, the preparation method of the compound represented by formula (VII) comprises the following steps:

(1)式(VIII)化合物在酸酐(較佳為三氟甲烷磺酸酐或對甲苯磺酸酐)和吡啶類鹼(較佳為2,4,6-三甲基吡啶、2,6-二甲基吡啶或吡啶)存在下發生反應;(1) Compound of formula (VIII) in acid anhydride (preferably trifluoromethanesulfonic anhydride or p-toluenesulfonic anhydride) and pyridine base (preferably 2,4,6-collidine, 2,6-dimethylpyridine) react in the presence of pyridine or pyridine);

(2)用鹼(較佳為無機鹼,進一步較佳為氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉或碳酸銫)調節步驟(1)得到的反應液pH至鹼性,較佳為調節pH為8-11;(2) Adjust the pH of the reaction solution obtained in step (1) to an alkali with an alkali (preferably an inorganic alkali, more preferably sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, sodium bicarbonate or cesium carbonate) It is better to adjust the pH to 8-11;

(3)用無機酸(較佳為硫酸、鹽酸、磷酸或硝酸)將步驟(2)得到的混合物進行酸化處理得式(VII)化合物。(3) The mixture obtained in step (2) is acidified with mineral acid (preferably sulfuric acid, hydrochloric acid, phosphoric acid or nitric acid) to obtain the compound of formula (VII).

根據本發明一些具體實施方案,其中,式(VII)所示化合物的製備方法包括如下步驟:

Figure 02_image031
According to some specific embodiments of the present invention, wherein, the preparation method of the compound represented by formula (VII) comprises the following steps:
Figure 02_image031

(1)式(VIII)化合物在三氟甲烷磺酸酐和吡啶類鹼存在下發生加成反應;(1) The compound of formula (VIII) undergoes an addition reaction in the presence of trifluoromethanesulfonic anhydride and a pyridine base;

(2)無機鹼調節反應液pH至鹼性,水解得到式(VII)和式(VII-1)混合物;其中無機鹼可以選自氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉、氟化銫或者碳酸銫;(2) The inorganic base adjusts the pH of the reaction solution to alkaline, and hydrolyzes to obtain a mixture of formula (VII) and formula (VII-1); wherein the inorganic base can be selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, carbonic acid Sodium hydrogen, cesium fluoride or cesium carbonate;

(3)在酸性條件下,對反應液進行酸化處理,調節pH為1-4,將步驟(2)得到的混合物中的式(VII-1)化合物發生重排反應得式(VII)化合物;其中,所述的酸為無機酸,選自硫酸、鹽酸、磷酸和硝酸中的一種或多種的混合。(3) Under acidic conditions, the reaction solution is acidified to adjust the pH to 1-4, and the compound of formula (VII-1) in the mixture obtained in step (2) is rearranged to obtain the compound of formula (VII); Wherein, the acid is an inorganic acid, selected from a mixture of one or more of sulfuric acid, hydrochloric acid, phosphoric acid and nitric acid.

在某些實施方案中,式(VII)所示的化合物的製備方法包括以下步驟:In certain embodiments, the preparation method of the compound represented by formula (VII) comprises the following steps:

(1)二氯甲烷或者1,2-二氯乙烷作溶劑,吡啶類的鹼和三氟甲烷磺酸酐存在下,式(VIII)發生加成反應;其中吡啶類的鹼是指包含吡啶結構的鹼,比如2,4,6-三甲基吡啶、2,6-二甲基吡啶或者吡啶;(1) In the presence of dichloromethane or 1,2-dichloroethane as a solvent, in the presence of a pyridine base and trifluoromethanesulfonic anhydride, the addition reaction of formula (VIII) occurs; wherein the pyridine base refers to a base containing a pyridine structure bases such as 2,4,6-collidine, 2,6-lutidine or pyridine;

(2)無機鹼調節反應液pH至鹼性,水解得到式(VII)和式(VII-1)混合物;其中無機鹼可以選自氫氧化鈉、氫氧化鉀、氫氧化鋰、碳酸鈉、碳酸氫鈉、氟化銫或者碳酸銫;pH至鹼性可以選自pH值為8-14、8-11、9-11或者10-11;(2) The inorganic base adjusts the pH of the reaction solution to alkaline, and hydrolyzes to obtain a mixture of formula (VII) and formula (VII-1); wherein the inorganic base can be selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, carbonic acid Sodium hydrogen, cesium fluoride or cesium carbonate; pH to alkaline can be selected from pH 8-14, 8-11, 9-11 or 10-11;

(3)在酸性條件下,式(VII)和式(VII-1)混合物中式(VII-1)化合物發生重排反應轉換為式(VII)化合物,其中反應的溶劑可以是對酸穩定的任何溶劑,在某些實施方案中選自丙酮或者乙腈。其中酸性條件可以選自pH值為1-4、1-3或者1-2,在某些實施方案中選自pH值1-2。所述的酸性條件可以是採用常用無機酸調節的,比如鹽酸、硫酸或者磷酸。(3) Under acidic conditions, the compound of formula (VII-1) in the mixture of formula (VII) and formula (VII-1) undergoes a rearrangement reaction and is converted into the compound of formula (VII), wherein the solvent of the reaction can be any acid stable. The solvent, in certain embodiments, is selected from acetone or acetonitrile. The acidic conditions may be selected from pH values of 1-4, 1-3 or 1-2, and in certain embodiments from pH values of 1-2. The acidic conditions can be adjusted by common inorganic acids, such as hydrochloric acid, sulfuric acid or phosphoric acid.

在某些實施方案中,式(VIII)化合物:吡啶類的鹼: 三氟甲烷磺酸酐的莫耳比為1: (1.1-2.0): (1.1-2.0),1: (1.1-1.5): (1.1-1.5)或者1: 1.5: 1.5。In certain embodiments, the compound of formula (VIII): pyridine base: trifluoromethanesulfonic anhydride has a molar ratio of 1:(1.1-2.0):(1.1-2.0), 1:(1.1-1.5): (1.1-1.5) or 1: 1.5: 1.5.

在某些具體實施方案,其中,式(VIII)化合物和吡啶類的鹼、三氟甲烷磺酸酐是在室溫至回流下進行反應。在某些實施方案中,在回流下進行反應。In certain embodiments, wherein the compound of formula (VIII) and the pyridine base, trifluoromethanesulfonic anhydride are reacted at room temperature to reflux. In certain embodiments, the reaction is carried out under reflux.

根據本發明一些具體實施方案,式(VIII)所示的化合物的製備方法還包括以式(IX)化合物為原料與二級胺NH(R3 )(R4 )反應製備式(VIII)化合物的步驟,

Figure 02_image033
According to some specific embodiments of the present invention, the preparation method of the compound represented by the formula (VIII) further includes the preparation of the compound of the formula (VIII) by reacting the compound of the formula (IX) with a secondary amine NH(R 3 )(R 4 ) as a raw material step,
Figure 02_image033

R3 、R4 定義同上。R 3 and R 4 are as defined above.

根據本發明一些具體實施方案,其中,式(IX)化合物與二級胺NH(R3 )(R4 )是在縮合劑存在下反應製備式(VIII)化合物。According to some specific embodiments of the present invention, wherein the compound of formula (IX) is reacted with a secondary amine NH(R 3 )(R 4 ) in the presence of a condensing agent to prepare the compound of formula (VIII).

其中二級胺的R3 和R4 定義如本發明前面所述。在一些具體實施方案中,R3 和R4 與所連接的氮原子形成四氫吡咯環。wherein R 3 and R 4 of the secondary amine are as defined previously in the present invention. In some specific embodiments, R 3 and R 4 form a tetrahydropyrrole ring with the nitrogen atom to which they are attached.

根據本發明一些具體實施方案,其中,所述縮合劑選自草醯氯、二氯亞碸、1-(3-二甲胺基丙基)-3-乙基碳二亞胺鹽酸鹽、1-羥基苯並三唑或者N,N'-羰基二咪唑。According to some specific embodiments of the present invention, wherein, the condensing agent is selected from the group consisting of oxalic chloride, dichlorosulfite, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 1-Hydroxybenzotriazole or N,N'-carbonyldiimidazole.

在某些實施方案中,式(IX)化合物與二級胺莫耳比不大於1,在某些實施方案中,莫耳比為1:1~5,在某些實施方案中,莫耳比為1:1~2,在某些實施方案中,莫耳比為1:1.1。In certain embodiments, the molar ratio of the compound of formula (IX) to the secondary amine is not greater than 1, in certain embodiments, the molar ratio is 1:1 to 5, and in certain embodiments, the molar ratio From 1:1 to 2, in certain embodiments, the molar ratio is 1:1.1.

在某些實施方案中,式(IX)化合物與二級胺NH(R3 )(R4 )反應製備式(VIII)化合物的反應溫度為室溫,在某些實施方案中,反應溫度為20~30℃。In certain embodiments, the reaction temperature of the compound of formula (IX) with the secondary amine NH( R3 )(R4) to prepare the compound of formula (VIII) is room temperature, in certain embodiments, the reaction temperature is 20 ~30°C.

根據本發明一些具體實施方案,其中,所述方法還包括以式(X)化合物為原料製備式(IX)化合物的步驟,

Figure 02_image035
。According to some specific embodiments of the present invention, wherein, the method further comprises the step of preparing the compound of formula (IX) by using the compound of formula (X) as a raw material,
Figure 02_image035
.

根據本發明一些具體實施方案,其中,是以式(X)化合物和丙二酸環(亞)異丙酯為原料製備式(IX)化合物。According to some specific embodiments of the present invention, wherein, the compound of formula (IX) is prepared from the compound of formula (X) and cyclo()isopropyl malonate as raw materials.

根據本發明一些具體實施方案,其中,是在三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物。According to some specific embodiments of the present invention, wherein, the compound of formula (X) is reacted with cyclo()isopropyl malonate under the catalysis of triethylamine formate to generate the compound of formula (IX).

根據本發明一些具體實施方案,其中,所述方法包括三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,並被還原脫羧生成式(IX)化合物。According to some specific embodiments of the present invention, wherein, the method comprises the reaction of the compound of formula (X) with cyclo()isopropyl malonate under the catalysis of triethylamine formate, and reductive decarboxylation to generate formula (IX) compound.

根據本發明一些具體實施方案,其中,所述三乙胺甲酸鹽可以由甲酸和三乙胺製備得到。According to some specific embodiments of the present invention, wherein, the triethylamine formate can be prepared from formic acid and triethylamine.

根據本發明一些具體實施方案,其中,式(X)化合物和丙二酸環(亞)異丙酯是以無水甲酸為反應介質進行反應。According to some specific embodiments of the present invention, wherein, the compound of formula (X) and cyclo()isopropyl malonate are reacted with anhydrous formic acid as the reaction medium.

在某些實施方案中,式(X)化合物與丙二酸環(亞)異丙酯莫耳比為不大於1,在某些實施方案中,莫耳比為1:1~5,在某些實施方案中,莫耳比為1:1~2,在某些實施方案中,莫耳比為1:1。In certain embodiments, the molar ratio of the compound of formula (X) to cyclo()isopropyl malonate is not greater than 1, in certain embodiments, the molar ratio is 1:1 to 5, and in certain In some embodiments, the molar ratio is from 1:1 to 2, and in certain embodiments, the molar ratio is 1:1.

根據本發明一些具體實施方案,式(X)化合物和丙二酸環(亞)異丙酯的反應溫度為100~180℃,在某些實施方案中,反應溫度為140~160℃,在某些實施方案中,反應溫度為140~150℃。According to some specific embodiments of the present invention, the reaction temperature of the compound of formula (X) and cyclo()isopropyl malonate is 100-180°C, in some embodiments, the reaction temperature is 140-160°C, and in a certain In some embodiments, the reaction temperature is 140-150°C.

根據本發明一些具體實施方案,式(X)化合物和丙二酸環(亞)異丙酯的反應後,還原脫羧反應是在酸性條件下進行的,其中酸性條件為pH值為1-5,在某些實施方案中為1-4,在某些實施方案中為1-3,在某些實施方案中為1-2。其中酸條件通過常用無機酸提供,例如鹽酸、硫酸或者磷酸。According to some specific embodiments of the present invention, after the reaction of the compound of formula (X) and cyclo()isopropyl malonate, the reductive decarboxylation reaction is carried out under acidic conditions, wherein the acidic conditions are pH 1-5, In certain embodiments 1-4, in certain embodiments 1-3, in certain embodiments 1-2. Where acid conditions are provided by common mineral acids such as hydrochloric acid, sulfuric acid or phosphoric acid.

本發明還提供了一種式(VII)所示的化合物的製備方法,其中,所述的方法包括以下步驟:

Figure 02_image037
The present invention also provides a preparation method of a compound shown in formula (VII), wherein the method comprises the following steps:
Figure 02_image037

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with cyclo()isopropyl malonate to generate the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )反應生成式(VIII)化合物;(2) The compound of formula (IX) reacts with secondary amine NH(R 3 )(R 4 ) to generate the compound of formula (VIII);

(3)式(VIII)化合物反應生成式(VII)化合物;(3) The compound of formula (VIII) is reacted to generate the compound of formula (VII);

R3 和R4 各自分別獨立的選自C1-6 的烷基;R 3 and R 4 are each independently selected from C 1-6 alkyl groups;

可選的,R3 和R4 和與其連接的碳原子共同形成環。Optionally, R3 and R4 together with the carbon atom to which they are attached form a ring.

根據本發明一些具體實施方案,其中,R3 和R4 與所連接的氮原子形成四氫吡咯環。According to some specific embodiments of the present invention, wherein, R 3 and R 4 form a tetrahydropyrrole ring with the nitrogen atom to which they are attached.

根據本發明一些具體實施方案,其中,所述方法包含如下步驟:According to some specific embodiments of the present invention, wherein, the method comprises the following steps:

(1)三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,生成式(IX)化合物;(1) Under the catalysis of triethylamine formate, the compound of formula (X) reacts with cyclo()isopropyl malonate to generate the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )反應生成式(VIII)化合物;(2) The compound of formula (IX) reacts with secondary amine NH(R 3 )(R 4 ) to generate the compound of formula (VIII);

(3)二氯甲烷或者1,2-二氯乙烷作溶劑,吡啶類的鹼存在下,式(VIII)與三氟甲烷磺酸酐反應後,無機鹼調節反應液pH至鹼性,再在酸性條件下製備得式(VII)化合物。(3) Dichloromethane or 1,2-dichloroethane is used as a solvent, in the presence of a pyridine base, after the formula (VIII) is reacted with trifluoromethanesulfonic anhydride, the pH of the reaction solution is adjusted to alkaline with an inorganic base, and then Compounds of formula (VII) are prepared under acidic conditions.

根據本發明一些具體實施方案,其中,所述方法包含如下步驟:According to some specific embodiments of the present invention, wherein, the method comprises the following steps:

(1)三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,並被還原脫羧生成式(IX)化合物;(1) Under the catalysis of triethylamine formate, the compound of formula (X) reacts with cyclo()isopropyl malonate, and is reduced and decarboxylated to generate the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) is subjected to condensation reaction with secondary amine NH(R 3 )(R 4 ) to generate the compound of formula (VIII);

(3)二氯甲烷或者1,2-二氯乙烷作溶劑,吡啶類的鹼存在下,式(VIII)與三氟甲烷磺酸酐反應後,無機鹼調節反應液pH至鹼性,再在酸性條件下製備得式(VII)化合物。(3) Dichloromethane or 1,2-dichloroethane is used as a solvent, in the presence of a pyridine base, after the formula (VIII) is reacted with trifluoromethanesulfonic anhydride, the pH of the reaction solution is adjusted to alkaline with an inorganic base, and then Compounds of formula (VII) are prepared under acidic conditions.

根據本發明一些具體實施方案,其中,步驟(2)是在縮合劑存在下發生縮合反應。According to some specific embodiments of the present invention, wherein, step (2) is a condensation reaction in the presence of a condensing agent.

根據本發明一些具體實施方案,其中,步驟(2)所述縮合劑選自草醯氯、二氯亞碸、1-(3-二甲胺基丙基)-3-乙基碳二亞胺鹽酸鹽、1-羥基苯並三唑或者N,N'-羰基二咪唑。According to some specific embodiments of the present invention, wherein, the condensing agent in step (2) is selected from the group consisting of oxalic chloride, dichlorosulfite, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide Hydrochloride, 1-hydroxybenzotriazole or N,N'-carbonyldiimidazole.

其中二級胺的R3 和R4 定義如本發明前面所述。wherein R 3 and R 4 of the secondary amine are as defined previously in the present invention.

在一些具體實施方案中,R3 和R4 與所連接的氮原子形成四氫吡咯環。In some specific embodiments, R 3 and R 4 form a tetrahydropyrrole ring with the nitrogen atom to which they are attached.

在一些實施方案中,製備式(VII)化合物的方法包含如下步驟:In some embodiments, methods of preparing compounds of formula (VII) comprise the steps of:

(1)、三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,並被還原脫羧生成式(IX)化合物;(1), under the catalysis of triethylamine formate, the compound of formula (X) reacts with cyclo(idene) isopropyl malonate, and is reduced and decarboxylated to generate compound of formula (IX);

(2)、式(IX)化合物與四氫吡咯發生縮合反應生成式(VIII)化合物;(2), the compound of formula (IX) reacts with tetrahydropyrrole to generate the compound of formula (VIII);

(3)、二氯甲烷或者1,2-二氯乙烷作溶劑,2,4,6-三甲基吡啶和三氟甲烷磺酸酐存在下,式(VIII)發生加成反應,然後用無機鹼調節反應液的pH至鹼性發生水解反應,再在酸性條件下發生重排反應得式(VII)化合物。(3), dichloromethane or 1,2-dichloroethane as solvent, in the presence of 2,4,6-trimethylpyridine and trifluoromethanesulfonic anhydride, formula (VIII) undergoes an addition reaction, and then uses inorganic The pH of the reaction solution is adjusted by alkali to be basic, and hydrolysis reaction is carried out, and then rearrangement reaction is carried out under acidic conditions to obtain the compound of formula (VII).

本發明還提供了一種純化式(VII)所示的化合物的方法:

Figure 02_image039
(VII)The present invention also provides a method for purifying the compound shown in formula (VII):
Figure 02_image039
(VII)

所述方法包括將式(VII)化合物與亞硫酸氫鈉常溫下加成成鹽,用有機溶劑萃取雜質,然後常溫下加酸或者鹼反應結束後經後處理即得。The method comprises the steps of adding the compound of formula (VII) and sodium hydrogen sulfite to a salt at room temperature, extracting impurities with an organic solvent, adding acid or base at room temperature and finishing the reaction after post-treatment.

在一些實施方案中,所述方法包括將式(VII)化合物與亞硫酸氫鈉加成成鹽,用有機溶劑萃取雜質,然後常溫下加酸或者鹼反應結束後經後處理得到高純度的式(VII)化合物:

Figure 02_image041
In some embodiments, the method comprises adding the compound of formula (VII) to sodium bisulfite to form a salt, extracting impurities with an organic solvent, then adding an acid or a base at room temperature and post-processing to obtain a high-purity formula (VII) Compounds:
Figure 02_image041

根據本發明的一些具體實施方案,上述後處理包括萃取、過濾、濃縮、乾燥等中的一個或多個操作。According to some specific embodiments of the present invention, the above post-processing includes one or more operations of extraction, filtration, concentration, drying, and the like.

根據本發明一些具體實施方案,其中,上述有機溶劑可以選自乙酸乙酯、二氯甲烷或者甲基第三丁基醚。According to some specific embodiments of the present invention, the above-mentioned organic solvent may be selected from ethyl acetate, dichloromethane or methyl tert-butyl ether.

根據本發明一些具體實施方案,其中,上述酸選自無機酸,比如鹽酸、硫酸或者磷酸。According to some specific embodiments of the present invention, wherein, the above acid is selected from inorganic acids, such as hydrochloric acid, sulfuric acid or phosphoric acid.

根據本發明一些具體實施方案,其中,上述酸選自鹽酸或硫酸。According to some specific embodiments of the present invention, wherein, the above acid is selected from hydrochloric acid or sulfuric acid.

根據本發明一些具體實施方案,其中,上述鹼選自無機鹼,比如氫氧化鈉。According to some specific embodiments of the present invention, wherein, the above-mentioned base is selected from inorganic bases, such as sodium hydroxide.

根據本發明一些具體實施方案,其中,式(VI)化合物與亞硫酸氫鈉加成成鹽在室溫條件下進行。According to some specific embodiments of the present invention, wherein, the addition salt of the compound of formula (VI) with sodium bisulfite is carried out at room temperature.

本發明還提供了一種式(I)所示的化合物的製備方法,其中,所述的方法包括以下步驟:The present invention also provides a preparation method of a compound shown in formula (I), wherein the method comprises the following steps:

(1)化合物(VII)發生Horner–Wadsworth–Emmons反應或者Wittig反應生成式(VI)化合物;(1) Compound (VII) undergoes Horner–Wadsworth–Emmons reaction or Wittig reaction to generate compound of formula (VI);

(2)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(2) The compound of formula (VI) reacts with nitromethane to generate the compound of formula (V);

(3)式(V)化合物發生還原反應後,與掌性酸反應得到式(III)化合物;(3) After the compound of formula (V) undergoes a reduction reaction, it reacts with a chiral acid to obtain a compound of formula (III);

(4)式(III)化合物反應生成式(I)化合物。(4) The compound of formula (III) is reacted to form the compound of formula (I).

根據本發明一些具體實施方案,式(III)化合物反應先得到式(II)化合物,再由式(II)化合物與酸A反應生成式(I)化合物。According to some specific embodiments of the present invention, the compound of formula (III) is first reacted to obtain the compound of formula (II), and then the compound of formula (II) is reacted with acid A to obtain the compound of formula (I).

根據本發明的一些具體實施方案,式(IV)化合物先反應得到式(XII)化合物,再由式(XII)化合物反應生成式(I)化合物,

Figure 02_image043
(XII);According to some specific embodiments of the present invention, the compound of formula (IV) is first reacted to obtain the compound of formula (XII), and then the compound of formula (XII) is reacted to generate the compound of formula (I),
Figure 02_image043
(XII);

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 .

本發明還提供了一種式(I)所示的化合物的製備方法,其中,所述的方法包括以下步驟:The present invention also provides a preparation method of a compound shown in formula (I), wherein the method comprises the following steps:

(1)以化合物(VII)為原料製備得到式(VI)化合物;(1) The compound of formula (VI) is prepared by using compound (VII) as a raw material;

(2)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(2) The compound of formula (VI) reacts with nitromethane to generate the compound of formula (V);

(3)式(V)化合物發生還原反應得到(Ⅳ),再與掌性酸(較佳為式(XI)化合物)反應得到式(III)化合物;(3) The compound of formula (V) undergoes reduction reaction to obtain (IV), and then reacts with chiral acid (preferably the compound of formula (XI)) to obtain the compound of formula (III);

(4)式(III)化合物通過反應得到式(II)化合物,再與酸A反應得到式(I)化合物;

Figure 02_image045
;(4) The compound of formula (III) is reacted to obtain the compound of formula (II), and then reacted with acid A to obtain the compound of formula (I);
Figure 02_image045
;

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from carboxyl protecting group or C 1-6 alkyl group; preferably R 2 is selected from tert-butyl group;

R11 選自C1-6 的烷基;較佳R11 選自甲基。R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

根據本發明的一些具體實施方案,所述的方法包括以下步驟:According to some specific embodiments of the present invention, the method comprises the following steps:

(1)化合物(VII)發生Horner–Wadsworth–Emmons反應或者Wittig反應生成式(VI)化合物;(1) Compound (VII) undergoes Horner–Wadsworth–Emmons reaction or Wittig reaction to generate compound of formula (VI);

(2)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(2) The compound of formula (VI) reacts with nitromethane to generate the compound of formula (V);

(3)式(V)化合物發生還原反應後,與掌性酸反應得到式(III)化合物;(3) After the compound of formula (V) undergoes a reduction reaction, it reacts with a chiral acid to obtain a compound of formula (III);

(4)式(III)化合物反應生成式(I)化合物;(4) The compound of formula (III) is reacted to generate the compound of formula (I);

根據本發明的一些具體實施方案,式(III)化合物反應先得到式(II)化合物,再由式(II)化合物與酸A反應生成式(I)化合物。According to some specific embodiments of the present invention, the compound of formula (III) is first reacted to obtain the compound of formula (II), and then the compound of formula (II) is reacted with acid A to obtain the compound of formula (I).

根據本發明的一些具體實施方案,式(V)化合物發生還原反應後,經水解後,再與掌性酸(較佳為式(XI)化合物)反應得到式(XII)化合物,式(XII)化合物經水解 ,再與酸A反應生成式(I)化合物;According to some specific embodiments of the present invention, after the compound of formula (V) undergoes a reduction reaction, after hydrolysis, it is then reacted with a chiral acid (preferably a compound of formula (XI)) to obtain a compound of formula (XII), formula (XII) The compound is hydrolyzed, and then reacts with acid A to generate the compound of formula (I);

根據本發明的一些具體實施方案,式(V)化合物發生還原反應後,先反應得到式(XII)化合物,再由式(XII)化合物反應生成式(I)化合物;

Figure 02_image047
(XII);According to some specific embodiments of the present invention, after the compound of formula (V) undergoes a reduction reaction, the compound of formula (XII) is first reacted to obtain the compound of formula (XII), and then the compound of formula (XII) is reacted to generate the compound of formula (I);
Figure 02_image047
(XII);

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from carboxyl protecting group or C 1-6 alkyl group; preferably R 2 is selected from tert-butyl group;

R11 選自C1-6 的烷基;較佳R11 選自甲基。R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

根據本發明的一些具體實施方案,

Figure 02_image048
According to some specific embodiments of the present invention,
Figure 02_image048

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from carboxyl protecting group or C 1-6 alkyl group; preferably R 2 is selected from tert-butyl group;

R11 選自C1-6 的烷基;較佳R11 選自甲基;R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl;

A選自苯磺酸、對甲苯磺酸或甲磺酸。A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid.

根據本發明一些具體實施方案,其中,所述的方法包括以下步驟:According to some specific embodiments of the present invention, wherein, the method comprises the following steps:

(1)鹼存在下,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯在10°C~40°C反應生成化合物(VI);(1) In the presence of a base, compound (VII) is reacted with tert-butyl dimethoxyphosphonoacetate at 10°C to 40°C to generate compound (VI);

(2)鹼存在下,化合物(VI)與硝基甲烷在80°C~100°C發生反應生成化合物(V);(2) In the presence of alkali, compound (VI) reacts with nitromethane at 80°C to 100°C to generate compound (V);

(3)甲醇溶劑中,氯化鎳六水合物作催化劑,硼氫化鈉作還原劑,化合物(V)發生還原反應後,與掌性酸在0-40°C下反應得到式(III)化合物;(3) In methanol solvent, nickel chloride hexahydrate is used as catalyst, sodium borohydride is used as reducing agent, after compound (V) undergoes reduction reaction, react with chiral acid at 0-40 ° C to obtain compound of formula (III) ;

(4)式(III)化合物水解得到式(II)化合物;(4) The compound of formula (III) is hydrolyzed to obtain the compound of formula (II);

(5)式(II)化合物與A反應得到式(I)化合物。(5) The compound of formula (II) is reacted with A to obtain the compound of formula (I).

根據本發明一些具體實施方案,其中,所述的方法包括以下步驟:According to some specific embodiments of the present invention, wherein, the method comprises the following steps:

(1)10°C~40°C和鹼存在下,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯反應生成化合物(VI);(1) Compound (VII) is reacted with tert-butyl dimethoxyphosphonoacetate at 10°C to 40°C and in the presence of a base to form compound (VI);

(2)80°C~100°C,鹼存在下,化合物(VI)與硝基甲烷發生反應生成化合物(V);(2) 80°C~100°C, in the presence of alkali, compound (VI) reacts with nitromethane to form compound (V);

(3)0-40°C,甲醇溶劑中,氯化鎳六水合物作催化劑,硼氫化鈉作還原劑,化合物(V)發生還原反應後,與掌性酸反應得到式(III)化合物;(3) 0-40 ℃, in methanol solvent, nickel chloride hexahydrate is used as catalyzer, sodium borohydride is used as reducing agent, after compound (V) takes place reduction reaction, react with chiral acid to obtain formula (III) compound;

(4)式(III)化合物水解得到式(II)化合物;(4) The compound of formula (III) is hydrolyzed to obtain the compound of formula (II);

(5)式(II)化合物與苯磺酸反應得到式(I)化合物。(5) The compound of formula (II) is reacted with benzenesulfonic acid to obtain the compound of formula (I).

根據本發明一些具體實施方案,其中,步驟(1)的鹼選自第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯。According to some specific embodiments of the present invention, wherein, the base of step (1) is selected from potassium tertiary butoxide or 1,8-diazabicycloundec-7-ene.

根據本發明一些具體實施方案,其中,步驟(2)的鹼選自碳酸銫、第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯。According to some specific embodiments of the present invention, wherein, the base in step (2) is selected from cesium carbonate, potassium tert-butoxide or 1,8-diazabicycloundec-7-ene.

根據本發明一些具體實施方案,其中,步驟(3)的掌性酸選自式(XI)化合物;

Figure 02_image016
(XI)According to some specific embodiments of the present invention, wherein, the chiral acid of step (3) is selected from compounds of formula (XI);
Figure 02_image016
(XI)

R1 定義同上。R 1 is as defined above.

根據本發明一些具體實施方案,其中,步驟(3)的掌性酸選自(S)-(+)-O-乙醯基-L-扁桃酸或L-扁桃酸。According to some specific embodiments of the present invention, wherein, the chiral acid in step (3) is selected from (S)-(+)-O-acetyl-L-mandelic acid or L-mandelic acid.

本發明還提供了一種式(I)所示的化合物的製備方法, 包括如下步驟:

Figure 02_image051
Figure 02_image053
The present invention also provides a method for preparing a compound represented by formula (I), comprising the following steps:
Figure 02_image051
Figure 02_image053

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with cyclo()isopropyl malonate to generate the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生反應生成式(VIII)化合物;(2) Compound of formula (IX) reacts with secondary amine NH(R 3 )(R 4 ) to generate compound of formula (VIII);

(3)式(VIII)化合物發生反應生成式(VII)化合物;(3) The compound of formula (VIII) reacts to generate the compound of formula (VII);

(4)以化合物(VII)為原料製備得到式(VI)化合物;(4) The compound of formula (VI) is prepared by using compound (VII) as a raw material;

(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(5) The compound of formula (VI) reacts with nitromethane to generate the compound of formula (V);

(6)式(V)化合物發生還原反應後,與掌性酸(較佳為式(XI)化合物)反應得到式(III)化合物;(6) After the compound of formula (V) undergoes a reduction reaction, react with a chiral acid (preferably a compound of formula (XI)) to obtain a compound of formula (III);

(7)式(III)化合物通過反應得到式(II)化合物,再與酸A反應生成式(I)化合物;(7) The compound of formula (III) is reacted to obtain the compound of formula (II), which is then reacted with acid A to generate the compound of formula (I);

或者式(V)化合物發生還原反應後,經水解後,再與掌性酸(較佳為式(XI)化合物)反應得到式(XII)化合物,式(XII)化合物經水解,再與酸A反應生成式(I)化合物;

Figure 02_image055
(V)
Figure 02_image057
(XII);Or after the compound of formula (V) undergoes a reduction reaction, after hydrolysis, it reacts with a chiral acid (preferably a compound of formula (XI)) to obtain a compound of formula (XII), and the compound of formula (XII) is hydrolyzed and then reacted with acid A The reaction generates the compound of formula (I);
Figure 02_image055
(V)
Figure 02_image057
(XII);

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from carboxyl protecting group or C 1-6 alkyl group; preferably R 2 is selected from tert-butyl group;

R11 選自C1-6 的烷基;較佳R11 選自甲基;R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl;

R3 和R4 各自分別獨立的選自C1-6 的烷基;R 3 and R 4 are each independently selected from C 1-6 alkyl groups;

可選的,R3 和R4 和與其連接的碳原子共同形成環(較佳R3 和R4 與所連接的氮原子形成吡啶環或四氫吡咯環)。Optionally, R3 and R4 together with the carbon atom to which they are attached form a ring (preferably R3 and R4 and the nitrogen atom to which they are attached form a pyridine ring or a tetrahydropyrrole ring).

本發明還提供了一種式(I)所示的化合物的製備方法, 包括如下步驟:The present invention also provides a method for preparing a compound represented by formula (I), comprising the following steps:

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with cyclo()isopropyl malonate to generate the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) is subjected to condensation reaction with secondary amine NH(R 3 )(R 4 ) to generate the compound of formula (VIII);

(3)式(VIII)化合物發生關環反應生成式(VII)化合物;(3) The compound of formula (VIII) undergoes a ring closure reaction to generate the compound of formula (VII);

(4)化合物(VII)發生Horner–Wadsworth–Emmons反應或者Wittig反應生成式(VI)化合物;(4) Compound (VII) undergoes Horner–Wadsworth–Emmons reaction or Wittig reaction to generate compound of formula (VI);

(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(5) The compound of formula (VI) reacts with nitromethane to generate the compound of formula (V);

(6)式(V)化合物發生還原反應後,與掌性酸反應得到式(III)化合物;(6) After the compound of formula (V) undergoes a reduction reaction, it reacts with a chiral acid to obtain a compound of formula (III);

(7)式(III)化合物反應生成式(I)化合物。(7) The compound of formula (III) is reacted to form the compound of formula (I).

根據本發明一些具體實施方案,式(III)化合物反應先得到式(II)化合物,再由式(II)化合物與酸A反應生成式(I)化合物。According to some specific embodiments of the present invention, the compound of formula (III) is first reacted to obtain the compound of formula (II), and then the compound of formula (II) is reacted with acid A to obtain the compound of formula (I).

根據本發明的一些具體實施方案,式(IV)化合物先反應得到式(XII)化合物,再由式(XII)化合物反應生成式(I)化合物;

Figure 02_image047
(XII);According to some specific embodiments of the present invention, the compound of formula (IV) is first reacted to obtain the compound of formula (XII), and then the compound of formula (XII) is reacted to form the compound of formula (I);
Figure 02_image047
(XII);

A、R1 、R2 、R3 、R4 等相關定義同上。The relevant definitions of A, R 1 , R 2 , R 3 and R 4 are the same as above.

本發明還提供了一種式(I)所示的化合物的製備方法,包括如下步驟:The present invention also provides a preparation method of the compound shown in formula (I), comprising the following steps:

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with cyclo()isopropyl malonate to generate the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) is subjected to condensation reaction with secondary amine NH(R 3 )(R 4 ) to generate the compound of formula (VIII);

(3)式(VIII)化合物發生關環反應生成式(VII)化合物;(3) The compound of formula (VIII) undergoes a ring closure reaction to generate the compound of formula (VII);

(4)化合物(VII)發生Horner–Wadsworth–Emmons反應或者Wittig反應生成式(VI)化合物;(4) Compound (VII) undergoes Horner–Wadsworth–Emmons reaction or Wittig reaction to generate compound of formula (VI);

(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(5) The compound of formula (VI) reacts with nitromethane to generate the compound of formula (V);

(6)式(V)化合物發生還原反應後,與掌性酸反應得到式(III)化合物;(6) After the compound of formula (V) undergoes a reduction reaction, it reacts with a chiral acid to obtain a compound of formula (III);

(7)式(III)化合物水解得到式(II)化合物;(7) The compound of formula (III) is hydrolyzed to obtain the compound of formula (II);

(8)式(II)化合物與酸A反應生成式(I)化合物。

Figure 02_image059
;(8) The compound of formula (II) reacts with acid A to form the compound of formula (I).
Figure 02_image059
;

A、R1 、R2 、R3 、R4 等相關定義同上。The relevant definitions of A, R 1 , R 2 , R 3 and R 4 are the same as above.

本發明還提供了一種式(I)所示的化合物的製備方法,包括如下步驟:The present invention also provides a preparation method of the compound shown in formula (I), comprising the following steps:

(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(1) The compound of formula (X) reacts with cyclo()isopropyl malonate to generate the compound of formula (IX);

(2)式(IX)化合物與二級胺NH(R3 )(R4 )發生縮合反應生成式(VIII)化合物;(2) The compound of formula (IX) is subjected to condensation reaction with secondary amine NH(R 3 )(R 4 ) to generate the compound of formula (VIII);

(3)式(VIII)化合物發生關環反應生成式(VII)化合物;(3) The compound of formula (VIII) undergoes a ring closure reaction to generate the compound of formula (VII);

(4)化合物(VII)發生HWE反應或者Wittig反應生成式(VI)化合物;(4) Compound (VII) undergoes HWE reaction or Wittig reaction to generate compound of formula (VI);

(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(5) The compound of formula (VI) reacts with nitromethane to generate the compound of formula (V);

(6)式(V)化合物發生還原反應後,水解得到化合物2B;(6) After the compound of formula (V) undergoes a reduction reaction, it is hydrolyzed to obtain compound 2B;

(7)化合物2B與掌性酸反應得到式(XII)化合物;(7) Compound 2B reacts with a chiral acid to obtain a compound of formula (XII);

(8)式(XII)化合物反應生成式(I)化合物。

Figure 02_image061
(8) The compound of formula (XII) is reacted to form the compound of formula (I).
Figure 02_image061

另一方面,本發明還提供了式(III)所示的化合物,

Figure 02_image063
(III)On the other hand, the present invention also provides a compound represented by formula (III),
Figure 02_image063
(III)

A選自苯磺酸、對甲苯磺酸或甲磺酸;A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid;

R1 選自H、羥基保護基或-C(=O)R11 ;R11 選自C1-6 的烷基;R 1 is selected from H, hydroxyl protecting group or -C(=O)R 11 ; R 11 is selected from C 1-6 alkyl;

R2 選自羧基保護劑或C1-6 的烷基;R 2 is selected from carboxyl protecting agent or C 1-6 alkyl;

R3 和R4 各自分別獨立的選自C1-6 的烷基;R 3 and R 4 are each independently selected from C 1-6 alkyl groups;

可選的,R3 和R4 和與其連接的碳原子共同形成環(較佳R3 和R4 與所連接的氮原子形成吡啶環或四氫吡咯環)。Optionally, R3 and R4 together with the carbon atom to which they are attached form a ring (preferably R3 and R4 and the nitrogen atom to which they are attached form a pyridine ring or a tetrahydropyrrole ring).

式(III)所示的化合物可以用作製備式(I)所示的化合物的中間體。The compound represented by the formula (III) can be used as an intermediate for the preparation of the compound represented by the formula (I).

根據本發明一些具體實施方案,其中,R11 選自甲基、乙基、丙基或第三丁基。According to some specific embodiments of the present invention, wherein, R 11 is selected from methyl, ethyl, propyl or tert-butyl.

根據本發明一些具體實施方案,其中,R2 選自甲基、乙基、丙基、或第三丁基。According to some specific embodiments of the present invention, wherein, R 2 is selected from methyl, ethyl, propyl, or tert-butyl.

本發明還提供了式(Ⅱ)所示的化合物,

Figure 02_image065
(Ⅱ)The present invention also provides a compound represented by formula (II),
Figure 02_image065
(II)

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基。R 2 is selected from carboxyl protecting groups or C 1-6 alkyl groups; preferably R 2 is selected from tertiary butyl groups.

本發明還提供了式(Ⅱ)所示的化合物的製備方法,所述方法包括以式(IV)化合物為原料,與掌性酸反應製備式(Ⅲ)化合物後水解得到式(Ⅱ)化合物,

Figure 02_image063
(Ⅲ)。The present invention also provides a method for preparing the compound represented by the formula (II), which comprises using the compound of the formula (IV) as a raw material, reacting with a chiral acid to prepare the compound of the formula (III), and then hydrolyzing to obtain the compound of the formula (II),
Figure 02_image063
(III).

根據本發明一些具體實施方案,其中,掌性酸為式(XI)所示的化合物,

Figure 02_image067
(XI)。According to some specific embodiments of the present invention, wherein, the chiral acid is a compound represented by formula (XI),
Figure 02_image067
(XI).

根據本發明一些具體實施方案,其中,掌性酸為L-扁桃酸。According to some specific embodiments of the present invention, wherein, the chiral acid is L-mandelic acid.

本發明還提供了式(XI)所示的化合物在製備式(II)化合物的對照品中的應用。The present invention also provides the application of the compound represented by the formula (XI) in preparing the reference substance of the compound of the formula (II).

本發明還提供了式(VIII)所示的化合物及其製備方法,

Figure 02_image069
(VIII)The present invention also provides a compound represented by formula (VIII) and a preparation method thereof,
Figure 02_image069
(VIII)

其中in

R3 和R4 各自獨立的選自C1-6 烷基或者R3 和R4 成環;R 3 and R 4 are each independently selected from C 1-6 alkyl or R 3 and R 4 form a ring;

條件是R3 和R4 不同時為甲基。 Provided that R3 and R4 are not both methyl.

根據本發明一些具體實施方案,其中, R3 和R4 與所連接的氮原子形成四氫吡咯環。According to some specific embodiments of the present invention, wherein, R 3 and R 4 form a tetrahydropyrrole ring with the nitrogen atom to which they are attached.

本發明還提供了下述化合物及其製備方法:

Figure 02_image071
Figure 02_image073
Figure 02_image075
Figure 02_image077
The present invention also provides the following compounds and their preparation methods:
Figure 02_image071
,
Figure 02_image073
,
Figure 02_image075
,
Figure 02_image077

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from carboxyl protecting group or C 1-6 alkyl group; preferably R 2 is selected from tert-butyl group;

R11 選自C1-6 的烷基;較佳R11 選自甲基。R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl.

本發明還提供了式(II)、式(III)、式(IV)、式(V)、式(VI)、式(VIII)或式(XII)化合物及其異構體或藥學上可接受的鹽,

Figure 02_image079
(II)、
Figure 02_image081
(III)
Figure 02_image071
Figure 02_image073
Figure 02_image075
Figure 02_image069
(VIII)、
Figure 02_image083
,The present invention also provides compounds of formula (II), formula (III), formula (IV), formula (V), formula (VI), formula (VIII) or formula (XII) and isomers or pharmaceutically acceptable compounds thereof of salt,
Figure 02_image079
(II),
Figure 02_image081
(III)
Figure 02_image071
,
Figure 02_image073
,
Figure 02_image075
,
Figure 02_image069
(VIII),
Figure 02_image083
,

R1 選自H、羥基保護基或-C(=O)R11R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ;

R2 選自羧基保護基或C1-6 的烷基;較佳R2 選自第三丁基;R 2 is selected from carboxyl protecting group or C 1-6 alkyl group; preferably R 2 is selected from tert-butyl group;

R11 選自C1-6 的烷基;較佳R11 選自甲基;R 11 is selected from C 1-6 alkyl; preferably R 11 is selected from methyl;

R3 和R4 各自獨立的選自C1-6 烷基或者R3 和R4 成環(較佳R3 和R4 與所連接的氮原子形成吡啶環或四氫吡咯環);R 3 and R 4 are each independently selected from C 1-6 alkyl or R 3 and R 4 form a ring (preferably R 3 and R 4 and the attached nitrogen atom form a pyridine ring or a tetrahydropyrrole ring);

條件是R3 和R4 不同時為甲基。 Provided that R3 and R4 are not both methyl.

本發明還提供了式(Ⅰ)所示的化合物的精製方法,其中,將式(I)化合物在有機溶劑(較佳為N-甲基吡咯烷酮或二甲亞碸)中加熱至溶解,加入乙酸異丙酯和/或水,攪拌析晶,過濾,減壓乾燥,即得:

Figure 02_image001
(I);The present invention also provides a method for purifying the compound represented by formula (I), wherein the compound of formula (I) is heated to dissolve in an organic solvent (preferably N-methylpyrrolidone or dimethylsulfoxide), and acetic acid is added. Isopropyl ester and/or water, stir and crystallize, filter, and dry under reduced pressure to obtain:
Figure 02_image001
(I);

A選自苯磺酸、對甲苯磺酸或甲磺酸。A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid.

根據本發明的一些具體實施方案,其中,將式(I)化合物粗品在N-甲基吡咯烷酮中加熱至80±5℃,待固體完全溶解後,加入活性炭攪拌,趁熱過濾,濾液加入乙酸異丙酯,攪拌析晶,過濾,即得。According to some specific embodiments of the present invention, wherein, the crude compound of formula (I) is heated to 80±5° C. in N-methylpyrrolidone, after the solid is completely dissolved, activated carbon is added to stir, filtered while hot, and isoacetic acid is added to the filtrate. Propyl ester, stirred for crystallization, filtered, and obtained.

根據本發明的一些具體實施方案,其中,將式(I)化合物粗品和二甲亞碸加熱至50±5℃,待固體完全溶解後,加入純化水,攪拌析晶。過濾,即得。According to some specific embodiments of the present invention, wherein the crude compound of formula (I) and dimethyl sulfite are heated to 50±5° C., after the solid is completely dissolved, purified water is added and stirred for crystallization. Filter and get it.

其中可以理解的是,本發明所涉及的製備方法是列舉了該方法所經過的反應步驟,而有些在本發明字面上是兩步或者兩步以上的反應步驟,但在實際中可以在一次反應操作中完成(即投料後無需出料得到中間產物,而繼續在反應液中進行下一步反應,如所謂「一鍋煮」的方式)而讓人誤以為是一步反應的,或者是在本發明字面上是一步反應,但可以在實際中將其拆成兩步或兩步以上反應步驟而讓人誤以為是多步反應的,均在本發明保護範圍之內。It can be understood that the preparation method involved in the present invention enumerates the reaction steps that the method goes through, and some are literally two or more reaction steps in the present invention, but in practice, one reaction can be performed in one reaction. It is completed in the operation (that is, after feeding, there is no need to discharge to obtain intermediate products, and continue to carry out the next step reaction in the reaction solution, such as the so-called "one-pot cooking" method) and people mistakenly think that it is a one-step reaction, or it is literally in the present invention. It is a one-step reaction, but it can be split into two or more reaction steps in practice to make people mistakenly think that it is a multi-step reaction, which is all within the protection scope of the present invention.

譬如在本發明實施例中,將式(III)化合物製備式(II)化合物,再以式(II)化合物製備式(I)化合物合併在一步反應操作中,應當理解這兩步反應均在本發明實施例中得到了記載。For example, in the embodiment of the present invention, the compound of formula (III) is used to prepare the compound of formula (II), and then the compound of formula (II) is used to prepare the compound of formula (I) in a one-step reaction operation. It is described in the invention examples.

同樣,在本發明實施例中,將式(Ⅴ)化合物製備式(Ⅳ)化合物,再以式(Ⅳ)化合物製備式(Ⅲ)化合物合併在一步反應操作中,應當理解這兩步反應均在本發明實施例中得到了記載。Similarly, in the embodiment of the present invention, the compound of formula (V) is prepared to the compound of formula (IV), and then the compound of formula (IV) is used to prepare the compound of formula (III) in one step reaction operation. It is described in the examples of the present invention.

本發明化學結構式中(+/-)表示所示結構與所示結構掌性完全相反的對映異構體的混合物。In the chemical structures of the present invention, (+/-) represents a mixture of enantiomers of the indicated structure with the exact opposite chirality to the indicated structure.

本發明反應過程的監測一般採用TLC、MS、LCMS或者/和核磁共振的方法。The monitoring of the reaction process of the present invention generally adopts the methods of TLC, MS, LCMS or/and nuclear magnetic resonance.

綜上所述,本發明提供了一種稠合三環γ-胺基酸衍生物的製備方法及中間體。本發明的製備方法具有如下優點:To sum up, the present invention provides a preparation method and an intermediate of a fused tricyclic γ-amino acid derivative. The preparation method of the present invention has the following advantages:

本發明式(VII)化合物極性很小,極易溶解於大多數溶劑,且熔點不高,難於重結晶純化。並且因為常溫下為固體,受熱容易昇華堵塞蒸餾裝置,且不耐受高溫,例行蒸餾或者減壓蒸餾不能純化。粗品純度只有50%,經過本發明精製後,純度可以在98%以上。The compound of formula (VII) of the present invention has a very small polarity, is easily dissolved in most solvents, and has a low melting point, so it is difficult to recrystallize and purify. And because it is solid at room temperature, it is easy to sublime and block the distillation device when heated, and it cannot withstand high temperature, so it cannot be purified by routine distillation or vacuum distillation. The purity of the crude product is only 50%, and after being purified by the present invention, the purity can be above 98%.

本發明的製備方法縮短了合成步驟,簡化了合成操作,且原料便宜易得,大大縮減了生產成品;其次,整個合成工藝都用結晶純化,沒有用到矽膠管柱層析或其他製備層析方法,適宜大規模工業化生產。The preparation method of the invention shortens the synthesis steps, simplifies the synthesis operation, and the raw materials are cheap and easy to obtain, which greatly reduces the production of finished products; secondly, the entire synthesis process is purified by crystallization, without using silica gel column chromatography or other preparation chromatography The method is suitable for large-scale industrial production.

以下結合附圖及實施例詳細說明本發明的技術方案,但本發明的保護範圍包括但是不限於此。The technical solutions of the present invention will be described in detail below with reference to the accompanying drawings and embodiments, but the protection scope of the present invention includes but is not limited thereto.

化合物的結構是通過核磁共振 ( NMR) 或 (和) 質譜 (MS) 來確定的。 NMR 位移 (δ) 以10-6 (ppm) 的單位給出。 NMR的測定是用 (BrukerAvance III 400和BrukerAvance 300) 核磁儀,測定溶劑為氘代二甲基亞碸 (DMSO-d6 ),氘代氯仿 (CDCl3 ),氘代甲醇 (CD3 OD),氘代乙腈(CD3 CN),內標為四甲基矽烷(TMS)。The structures of the compounds were determined by nuclear magnetic resonance (NMR) or (and) mass spectrometry (MS). NMR shifts (δ) are given in units of 10 -6 (ppm). NMR was measured using (BrukerAvance III 400 and BrukerAvance 300) nuclear magnetic instruments, and the solvents were deuterated dimethylsulfoxide (DMSO-d 6 ), deuterated chloroform (CDCl 3 ), deuterated methanol (CD 3 OD), Deuterated acetonitrile (CD 3 CN), the internal standard is tetramethylsilane (TMS).

MS的測定用Agilent 6120B(ESI) 和Agilent 6120B(APCI)。For MS measurement, Agilent 6120B (ESI) and Agilent 6120B (APCI) were used.

HPLC的測定使用安捷倫1260DAD高壓液相層析儀 (Zorbax SB-C18 100×4.6 mm)。The HPLC measurement was performed using an Agilent 1260DAD high pressure liquid chromatograph (Zorbax SB-C18 100×4.6 mm).

薄層層析矽膠板使用煙臺黃海HSGF254 或青島GF254 矽膠板,薄層層析法 (TLC) 使用的矽膠板採用的規格是0.15 mm~0.20 mm,薄層層析分離純化產品採用的規格是0.4 mm~0.5 mm。The thin layer chromatography silica gel plate uses Yantai Huanghai HSGF254 or Qingdao GF254 silica gel plate, the size of the silica gel plate used for thin layer chromatography (TLC) is 0.15 mm~0.20 mm, and the size of the TLC separation and purification products is 0.4 mm mm~0.5 mm.

管柱層析一般使用煙臺黃海矽膠200~300目矽膠為載體。Column chromatography generally uses Yantai Huanghai silica gel 200~300 mesh silica gel as the carrier.

本發明的已知的起始原料可以採用或按照本領域已知的方法來合成,或可購買於泰坦科技、安耐吉化學、上海德默、成都科龍化工、韶遠化學科技、百靈威科技等公司。The known starting materials of the present invention can be synthesized by using or according to methods known in the art, or can be purchased from Titan Technology, Annagy Chemical, Shanghai Demo, Chengdu Kelong Chemical, Shaoyuan Chemical Technology, Bailingwei Technology and other companies.

本發明矽膠管柱層析所示比例為體積比。實施例 1 The ratio shown in the silica gel column chromatography of the present invention is the volume ratio. Example 1

2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸 苯磺酸鹽(1:1)  (化合物1)2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid benzenesulfonate (1:1 ) (Compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image086
Figure 02_image088
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image086
Figure 02_image088

第一步:3-(環己基-3-烯-1-基)丙酸(1B)The first step: 3-(cyclohexyl-3-en-1-yl)propionic acid (1B)

3-(cyclohex-3-en-1-yl)propanoic acid

Figure 02_image090
3-(cyclohex-3-en-1-yl)propanoic acid
Figure 02_image090

將無水甲酸(18.82 kg, 409.09 mol)抽入100升的反應釜中,抽畢。降溫至10℃。將三乙胺(16.53 kg, 163.64mol)滴加到反應液中,加畢, 攪拌20分鐘,當內溫為10℃時,將丙二酸環(亞)異丙酯(7.86 kg, 54.55 mol)加入反應釜,再將3-環己烯-1-甲醛(6.00 kg, 54.55 mol)於內溫40℃下滴加到反應液中,加畢,程序升溫到140-150℃反應至無氣體再放出。用6 N 鹽酸(24.0 L)調節反應液pH 1-2之間。水相用二氯甲烷(12L × 2)萃取產品,合併有機相,並用飽和食鹽水(10L×2)洗滌。有機相用無水硫酸鈉(2.0 kg)乾燥1小時,過濾,濾液濃縮蒸乾得黃色油狀物1B (8.80 kg)。Anhydrous formic acid (18.82 kg, 409.09 mol) was pumped into a 100-liter reaction kettle, and the pumping was completed. Cool down to 10°C. Triethylamine (16.53 kg, 163.64 mol) was added dropwise to the reaction solution, the addition was completed, and the mixture was stirred for 20 minutes. When the internal temperature was 10 °C, cyclo(idene)isopropyl malonate (7.86 kg, 54.55 mol) was added. ) was added to the reaction kettle, and then 3-cyclohexene-1-carbaldehyde (6.00 kg, 54.55 mol) was added dropwise to the reaction solution at an internal temperature of 40 °C. release again. Adjust the pH of the reaction solution between 1-2 with 6 N hydrochloric acid (24.0 L). The aqueous phase was extracted with dichloromethane (12L×2), and the organic phases were combined and washed with saturated brine (10L×2). The organic phase was dried with anhydrous sodium sulfate (2.0 kg) for 1 hour, filtered, and the filtrate was concentrated and evaporated to dryness to obtain a yellow oil 1B (8.80 kg).

1 H NMR (400 MHz, CDCl3 ) δ 10.23 (s, 1H), 5.73 – 5.55 (m, 2H), 2.46 – 2.30 (m, 2H), 2.09 – 1.96 (m, 2H), 1.81 – 1.53 (m, 6H), 1.35 – 1.17 (m, 1H)。 1 H NMR (400 MHz, CDCl 3 ) δ 10.23 (s, 1H), 5.73 – 5.55 (m, 2H), 2.46 – 2.30 (m, 2H), 2.09 – 1.96 (m, 2H), 1.81 – 1.53 (m , 6H), 1.35 – 1.17 (m, 1H).

LCMS m/z =153.1 [M-1]。LCMS m/z = 153.1 [M-1].

第二步:3-(環己基-3-烯-1-基)-1-(吡咯烷基-1-基)丙基-1-酮(1C)Step 2: 3-(Cyclohexyl-3-en-1-yl)-1-(pyrrolidin-1-yl)propyl-1-one (1C)

3-(cyclohex-3-en-1-yl)-1-(pyrrolidin-1-yl)propan-1-one

Figure 02_image092
3-(cyclohex-3-en-1-yl)-1-(pyrrolidin-1-yl)propan-1-one
Figure 02_image092

1B (11.20kg, 72.727mol)用二氯甲烷(60.0L)溶解後,抽入100L反應釜中。加入DMF(3.0 mL)並將草醯氯(9.046kg, 71.272 mol)滴加到反應液中。加畢,室溫攪拌2.0小時。將四氫吡咯(5.689kg, 79.999mol)和三乙胺(8.814kg, 87.272 mol)先後滴加入反應釜中。控制內溫低於10℃,加畢,於室溫下攪拌過夜。將反應液冷卻至10℃。滴加3N鹽酸(20.0 L)調節反應液pH1-2之間。靜置,分液,水相用二氯甲烷(10.0 L× 1)萃取。合併有機相,依次用5%氫氧化鈉溶液(10.0 L×1),飽和氯化銨溶液(20.0 L×1)洗滌。有機相用無水硫酸鈉(2.0 kg)乾燥30分鐘後,過濾,濾液濃縮得到棕色液體1C (15.00kg,收率99.6%)。After dissolving 1B (11.20kg, 72.727mol) in dichloromethane (60.0L), it was pumped into a 100L reaction kettle. DMF (3.0 mL) was added and oxalic chloride (9.046 kg, 71.272 mol) was added dropwise to the reaction. After the addition was completed, the mixture was stirred at room temperature for 2.0 hours. Tetrahydropyrrole (5.689kg, 79.999mol) and triethylamine (8.814kg, 87.272mol) were added dropwise to the reaction kettle successively. The inner temperature was controlled to be lower than 10°C, the addition was completed, and the mixture was stirred at room temperature overnight. The reaction liquid was cooled to 10°C. 3N hydrochloric acid (20.0 L) was added dropwise to adjust the pH of the reaction solution between 1-2. After standing, the solution was separated, and the aqueous phase was extracted with dichloromethane (10.0 L×1). The organic phases were combined and washed successively with 5% sodium hydroxide solution (10.0 L×1) and saturated ammonium chloride solution (20.0 L×1). The organic phase was dried with anhydrous sodium sulfate (2.0 kg) for 30 minutes, filtered, and the filtrate was concentrated to obtain a brown liquid 1C (15.00 kg, yield 99.6%).

1 H NMR (400 MHz, CDCl3 ) δ 5.73 – 5.56 (m, 2H), 3.43 (dd, 4H), 2.37 – 2.22 (m, 2H), 2.16 – 2.01 (m, 4H), 1.90 (dt, 4H), 1.81 – 1.51 (m, 6H), 1.30 – 1.15 (m, 2H)。 1 H NMR (400 MHz, CDCl 3 ) δ 5.73 – 5.56 (m, 2H), 3.43 (dd, 4H), 2.37 – 2.22 (m, 2H), 2.16 – 2.01 (m, 4H), 1.90 (dt, 4H) ), 1.81 – 1.51 (m, 6H), 1.30 – 1.15 (m, 2H).

LCMS m/z =208.1 [M+1]。LCMS m/z = 208.1 [M+1].

第三步:三環[4.2.1.03,8 ]壬烷基-2-酮(1R,3S,6R,8R 和 1S,3R,6S,8S消旋體)(1D)The third step: tricyclo[ 4.2.1.03,8 ]nonyl-2-one (1R,3S,6R,8R and 1S,3R,6S,8S racemate) (1D)

tricyclo[4.2.1.03,8 ]nonan-2-one (1R,3S,6R,8R and 1S,3R,6S,8S racemate)

Figure 02_image094
tricyclo[4.2.1.0 3,8 ]nonan-2-one (1R,3S,6R,8R and 1S,3R,6S,8S racemate)
Figure 02_image094

1C (5.64 kg,27.22 mol)用二氯甲烷(40.0 L)溶解後,抽入100L的反應釜中。降溫至-10℃,加入2,4,6-三甲基吡啶(4.94 kg,40.83 mol)。將三氟甲烷磺酸酐(11.50kg,40.83 mol)的二氯甲烷溶液(16.0 L)滴加到反應液中,加畢。加熱回流12小時。中控檢測反應完全後,將氫氧化鈉(3.10 kg,77.5 mol)的水溶液 (23.0 L)滴加到反應液中,調節反應液pH 10-11之間。繼續回流5-6小時。靜置分液,水相用二氯甲烷 (5.0L × 1) 萃取,合併有機相。將有機相抽入反應釜中,降溫到10℃。滴加2.0 N鹽酸溶液(20.0 L)調節反應液pH 1-2之間。靜置分液,有機相用飽和食鹽水(20L× 1) 洗滌,濃縮,殘留物用丙酮(20.0 L)溶解後,抽入100L反應釜中攪拌,滴加濃硫酸(4.0 L)和水(20.0 L)的配製溶液,加畢回流2小時。降溫到15℃,向反應液中加入飽和食鹽水(20.0 L),並用正己烷(15.0L×2)萃取。合併有機相,用飽和食鹽水(20.0 L×1)洗滌,有機相用無水硫酸鈉乾燥過夜。過濾,濾液減壓濃縮後得黃色固體粗品1D (3.00kg,收率81%),純度為50%。After dissolving 1C (5.64 kg, 27.22 mol) with dichloromethane (40.0 L), it was pumped into a 100 L reaction kettle. The temperature was lowered to -10°C, and 2,4,6-collidine (4.94 kg, 40.83 mol) was added. A dichloromethane solution (16.0 L) of trifluoromethanesulfonic anhydride (11.50 kg, 40.83 mol) was added dropwise to the reaction solution, and the addition was completed. Heat to reflux for 12 hours. After the central control detection reaction was completed, an aqueous solution (23.0 L) of sodium hydroxide (3.10 kg, 77.5 mol) was added dropwise to the reaction solution, and the pH of the reaction solution was adjusted between 10-11. Continue to reflux for 5-6 hours. After standing for separation, the aqueous phase was extracted with dichloromethane (5.0L × 1), and the organic phases were combined. The organic phase was pumped into the reactor and cooled to 10°C. 2.0 N hydrochloric acid solution (20.0 L) was added dropwise to adjust the pH of the reaction solution between 1-2. Let stand for separation, the organic phase was washed with saturated brine (20L×1), concentrated, the residue was dissolved in acetone (20.0L), pumped into a 100L reaction kettle and stirred, and concentrated sulfuric acid (4.0L) and water ( 20.0 L) of the prepared solution, and refluxed for 2 hours after the addition. The temperature was lowered to 15°C, and saturated brine (20.0 L) was added to the reaction solution, followed by extraction with n-hexane (15.0 L×2). The organic phases were combined, washed with saturated brine (20.0 L×1), and the organic phases were dried over anhydrous sodium sulfate overnight. After filtering, the filtrate was concentrated under reduced pressure to obtain a yellow solid crude product 1D (3.00kg, yield 81%) with a purity of 50%.

1D進一步純化步驟:1D Further purification steps:

方法1:將無水亞硫酸氫鈉(5.735kg,55.147mol)溶於66L純化水中並加入到100L的反應釜中,室溫攪拌下加入1D 粗品(3.00kg,22.059mol)的乙醇(3.0L)溶液,加畢於室溫下攪拌過夜,用乙酸乙酯(20L×2)萃取,水相加入反應釜中攪拌並降溫到10℃下,滴加入氫氧化鈉(2.250kg,56.250mol)的水(10L)溶液,調pH至10-12,加畢於室溫下攪拌2小時,用正己烷(20L×2)萃取,合併有機相並用純化水(20L×1)洗滌,有機相用無水硫酸鈉(2kg)乾燥1小時,過濾,將濾液蒸乾得1D ,無色晶狀固體(2.7kg,收率90%)測定純度為98.3%。Method 1: Dissolve anhydrous sodium bisulfite (5.735kg, 55.147mol) in 66L of purified water and add it to a 100L reactor, add ethanol (3.0L) of 1D crude product (3.00kg, 22.059mol) under stirring at room temperature The solution was added and stirred overnight at room temperature, extracted with ethyl acetate (20L×2), the aqueous phase was added to the reaction kettle and stirred and cooled to 10°C, and water of sodium hydroxide (2.250kg, 56.250mol) was added dropwise. (10L) solution, adjust the pH to 10-12, stir at room temperature for 2 hours, extract with n-hexane (20L×2), combine the organic phases and wash with purified water (20L×1), the organic phase is washed with anhydrous sulfuric acid Sodium (2 kg) was dried for 1 hour, filtered, and the filtrate was evaporated to dryness to obtain 1D . The measured purity of the colorless crystalline solid (2.7 kg, yield 90%) was 98.3%.

方法2:將亞硫酸氫鈉(1529 g,14.706mol)溶於22L水中,攪拌下滴加入1D粗品(1000g,7.353mol)的無水乙醇(1000mL)溶液,加畢於室溫攪拌過夜(24小時)。反應液用二氯甲烷(5L×2)萃取除雜,向水相滴加入硫酸溶液(6.4L濃硫酸和6公斤碎冰配製而成),室溫下攪拌5小時,反應液用正己烷(萃取3-4次,每次4L)萃取,合併有機相並用飽和氯化鈉水溶液(5L×2)洗滌,有機相用1kg無水硫酸鈉乾燥2小時,過濾,濾液蒸乾得1D 白色固體(900g,收率:90%),測定純度為98.1%。Method 2: Dissolve sodium bisulfite (1529 g, 14.706 mol) in 22 L of water, add dropwise a solution of 1D crude product (1000 g, 7.353 mol) in absolute ethanol (1000 mL) under stirring, and stir at room temperature overnight (24 hours) ). The reaction solution was extracted with dichloromethane (5L×2) to remove impurities, and a sulfuric acid solution (prepared with 6.4L concentrated sulfuric acid and 6 kg of crushed ice) was added dropwise to the aqueous phase, stirred at room temperature for 5 hours, and the reaction solution was washed with n-hexane ( Extract 3-4 times, 4L each time), combine the organic phases and wash with saturated aqueous sodium chloride solution (5L×2), dry the organic phase with 1kg anhydrous sodium sulfate for 2 hours, filter, and evaporate the filtrate to dryness to obtain 1D , a white solid ( 900 g, yield: 90%), the measured purity was 98.1%.

1 H NMR (400 MHz, CDCl3 )δ 3.39 (m, 1H), 3.19 (m, 1H), 2.77 (m, 1H), 2.38 (m, 1H), 2.05 (m, 1H), 1.93 (d, 1H), 1.77 (m, 1H), 1.45 (m, 4H), 1.20 (m, 1H)。 1 H NMR (400 MHz, CDCl 3 )δ 3.39 (m, 1H), 3.19 (m, 1H), 2.77 (m, 1H), 2.38 (m, 1H), 2.05 (m, 1H), 1.93 (d, 1H), 1.77 (m, 1H), 1.45 (m, 4H), 1.20 (m, 1H).

LCMS m/z =137.1 [M+1]。LCMS m/z = 137.1 [M+1].

第四步:第三丁基 2-(三環[4.2.1.03,8 ]壬烷基-2-葉立德烯)乙酸酯(1R,3S,6R,8R和1S,3R,6S,8S消旋體)(1E)The fourth step: tertiary butyl 2-(tricyclo[4.2.1.0 3,8 ]nonyl-2-ylidene) acetate (1R,3S,6R,8R and 1S,3R,6S,8S elimination Rotary body) (1E)

tert-butyl 2-tricyclo[4.2.1.03,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)

Figure 02_image096
tert-butyl 2-tricyclo[4.2.1.0 3,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)
Figure 02_image096

將第三丁醇鉀(742.0 g, 6.62 mol)和四氫呋喃(6.20 L) 加入20 L反應釜中。降溫到5℃,滴加二甲氧基膦醯基乙酸第三丁酯(1480 g, 6.62 mol, 1.1eq)到反應液中,控制反應溫度10℃-15℃,繼續攪拌1小時。再將1D (820.0 g, 6.02 mol, 1.0 eq)的四氫呋喃(2.0 L)溶液滴加到反應液中,1小時內滴加完,加畢自然升到室溫反應2小時。向反應釜依次加入飽和氯化銨(2.0 L)溶液,純化水(2.0 L)。攪拌20分鐘後靜置分層,水相用甲基第三丁基醚(1.5 L×2)萃取。合併有機相,用飽和食鹽水(2 L×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到1E 黃色液體(1.50 kg)。Potassium tertiary butoxide (742.0 g, 6.62 mol) and tetrahydrofuran (6.20 L) were added to a 20 L reaction kettle. The temperature was lowered to 5°C, tert-butyl dimethoxyphosphonoacetate (1480 g, 6.62 mol, 1.1 eq) was added dropwise to the reaction solution, the reaction temperature was controlled to 10°C-15°C, and stirring was continued for 1 hour. Then 1D (820.0 g, 6.02 mol, 1.0 eq) solution in tetrahydrofuran (2.0 L) was added dropwise to the reaction solution, the addition was completed within 1 hour, and the reaction was naturally raised to room temperature for 2 hours. Saturated ammonium chloride (2.0 L) solution and purified water (2.0 L) were successively added to the reaction kettle. After stirring for 20 minutes, the mixture was left to stand for layers, and the aqueous phase was extracted with methyl tert-butyl ether (1.5 L×2). The organic phases were combined, washed with saturated brine (2 L×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave IE as a yellow liquid (1.50 kg).

LCMS m/z =235.3 [M+1]。LCMS m/z = 235.3 [M+1].

第五步:第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)The fifth step: tertiary butyl 2-(2-(nitromethyl) tricyclo[4.2.1.0 3,8 ] nonyl-2-yl) acetate (1R, 2R, 3S, 6R, 8R and 1S, 2S, 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image098
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image098

向20L反應釜中依次加入1E (1.40 kg, 5.97 mol, 1.0 eq),硝基甲烷(1.82 kg, 29.85 mol, 5.0 eq)和二甲基亞碸(9.8 L)。攪拌,將碳酸銫 (2.34 kg, 7.16 mol, 1.2 eq)加到反應液中。加畢,加熱到80℃-85℃,繼續保溫反應5小時後冷卻到室溫,向反應釜加入純化水(20.0 L),水相用甲基第三丁基醚(8.0 L×3)萃取。合併有機相,用飽和食鹽水(8.0 L×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到棕色液體1F (1.62 kg,產率:92%)。 1E (1.40 kg, 5.97 mol, 1.0 eq), nitromethane (1.82 kg, 29.85 mol, 5.0 eq) and dimethylsulfite (9.8 L) were sequentially added to the 20L reactor. With stirring, cesium carbonate (2.34 kg, 7.16 mol, 1.2 eq) was added to the reaction. After adding, heat to 80°C-85°C, continue the reaction for 5 hours and then cool to room temperature, add purified water (20.0 L) to the reactor, and extract the aqueous phase with methyl tertiary butyl ether (8.0 L×3) . The organic phases were combined, washed with saturated brine (8.0 L×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave brown liquid 1F (1.62 kg, yield: 92%).

LCMS m/z =318.1 [M+23]。LCMS m/z = 318.1 [M+23].

第六步:第三丁基2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(S)-2-乙醯氧基-2苯乙酸(1H)The sixth step: tertiary butyl 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)ethyl Acetate (S)-2-acetoxy-2-phenylacetic acid (1H)

tert-butyl2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (S)-2-acetoxy-2-phenylacetate

Figure 02_image100
tert-butyl2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (S)-2-acetoxy-2-phenylacetate
Figure 02_image100

向50L反應釜加入1F (730.0 g, 2.47 mol)和甲醇(7.3 L)。攪拌,將氯化鎳六水合物(118 g, 0.49 mol, 0.2 eq)加到反應中,反應液降溫到5℃,分批加入硼氫化鈉(374 g, 9.88 mol, 4.0 eq),保持反應體系溫度20℃-30℃,約3小時加完。加畢繼續攪拌反應2小時。向反應釜加入冰水(16.4 L),水相用矽藻土過濾。濾液用二氯甲烷(3.0 L×2)萃取合併有機相,用飽和食鹽水(4 L×1)洗滌,無水硫酸鈉乾燥。過濾,濾液加入(S)-(+)-O-乙醯基-L-扁桃酸(384 g, 1.97 mol, 0.8 eq),加畢攪拌20分鐘。將有機相蒸餾濃縮直到無溶劑蒸出後,用異丙醇(5.9 L)攪拌打漿2小時,降溫到5℃攪拌1小時。過濾,濾餅用異丙醇洗滌(0.4 L×1),烘乾得到白色固體產品1H 粗品(422 g,產率:34.96%)。取固體經衍生後測定ee值為48.35%。To a 50L autoclave was added 1F (730.0 g, 2.47 mol) and methanol (7.3 L). With stirring, nickel chloride hexahydrate (118 g, 0.49 mol, 0.2 eq) was added to the reaction, the reaction solution was cooled to 5 °C, and sodium borohydride (374 g, 9.88 mol, 4.0 eq) was added in batches to maintain the reaction The temperature of the system is 20°C-30°C, and the addition is completed in about 3 hours. After the addition was completed, stirring was continued for 2 hours. Ice water (16.4 L) was added to the autoclave, and the aqueous phase was filtered through celite. The filtrate was extracted with dichloromethane (3.0 L×2), and the organic phases were combined, washed with saturated brine (4 L×1), and dried over anhydrous sodium sulfate. Filter, add (S)-(+)-O-acetyl-L-mandelic acid (384 g, 1.97 mol, 0.8 eq) to the filtrate, and stir for 20 minutes after the addition. The organic phase was concentrated by distillation until no solvent was evaporated, and then stirred and slurried with isopropanol (5.9 L) for 2 hours, and then cooled to 5° C. and stirred for 1 hour. Filtration, the filter cake was washed with isopropanol (0.4 L×1), and dried to obtain a white solid product 1H crude product (422 g, yield: 34.96%). The ee value was determined to be 48.35% after the solid was derivatized.

第一次結晶:將粗產品1H (420.0 g, 0.92mol),異丙醇(4.20 L)和水(0.21 L)依次加入反應釜中。程序升溫至82℃,使固體完全溶解,保溫0.5小時。降溫至20℃析晶,約6小時。內溫至20℃時,過濾,濾餅用異丙醇(0.40 L×1)洗滌。合併固體,60-65℃鼓風乾燥4小時烘乾至恆重。得1H 第一次結晶物(260 g,產率:62%),取固體衍生後測定ee值為81.25%。The first crystallization: The crude product 1H (420.0 g, 0.92 mol), isopropanol (4.20 L) and water (0.21 L) were successively added to the reaction kettle. The temperature was programmed to 82°C to completely dissolve the solids and held for 0.5 hours. Cool to 20°C for crystallization for about 6 hours. When the internal temperature reaches 20 °C, filter, and wash the filter cake with isopropanol (0.40 L×1). The solids were combined and dried by blasting at 60-65°C for 4 hours to constant weight. The first 1H crystallized product (260 g, yield: 62%) was obtained, and the ee value was determined to be 81.25% after derivatization of the solid.

第二次結晶:將1H 第一次結晶物(177 g, 0.39 mol),異丙醇(2.53 L)和水(0.126 L)依次加入反應釜中。程序升溫至82℃,使固體完全溶解,保溫0.5小時。降溫至20℃析晶,約4.5小時。內溫至30℃時,過濾,濾餅用異丙醇(0.10 L×1)洗滌。合併固體,60-65℃鼓風乾燥4小時烘乾至恆重。得白色固體1H 純品(128 g,產率:72%),取固體衍生後測定ee值為99.73%。The second crystallization: The first 1H crystallized product (177 g, 0.39 mol), isopropanol (2.53 L) and water (0.126 L) were added to the reaction kettle in turn. The temperature was programmed to 82°C to completely dissolve the solids and held for 0.5 hours. Cool to 20°C for crystallization for about 4.5 hours. When the internal temperature reaches 30°C, filter, and wash the filter cake with isopropanol (0.10 L×1). The solids were combined and dried by blasting at 60-65°C for 4 hours to constant weight. A white solid 1H pure product (128 g, yield: 72%) was obtained, and the ee value was determined to be 99.73% after derivatization of the solid.

LCMS m/z =266.3 [M+1]。LCMS m/z = 266.3 [M+1].

第七步:2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸苯磺酸化合物 (1:1)(化合物1)The seventh step: 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetic acid benzenesulfonic acid compound (1:1) (Compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image102
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image102

1H 純品(100.0 g,0.218 mol)和純化水(0.8 L)依次加入反應釜中,降溫到0-10℃。內溫至0-10 ℃,滴加 1 mol / L NaOH(218 mL)水溶液到反應釜中,調節反應液pH 9-10。靜置分層,水相用二氯甲烷(0.30 L×2)萃取。合併有機相,依次用 1 mol / L NaOH(0.10 L×1)溶液和飽和食鹽水(0.15 L×1)洗滌。有機相中加入活性炭(5.0 g)脫色,無水硫酸鈉乾燥。過濾,濾液濃縮,濃縮釜中剩餘物用乙腈(280 mL)溶解。將苯磺酸一水合物(77.0 g,0.437 mol)用純化水(280 mL)配製成溶液滴加至上述乙腈溶液中,加畢。程序升溫至80-85℃,保溫反應4-6小時。將反應液降溫至10-20℃析晶,約4-6小時。內溫至10-20℃時,過濾,濾餅依次用水(30 mL×1),乙腈(50 mL×1)洗滌。乾燥後得到化合物 1 白色固體 (72 g,產率:90%)。 1H pure product (100.0 g, 0.218 mol) and purified water (0.8 L) were added to the reaction kettle in turn, and the temperature was lowered to 0-10 °C. The internal temperature was raised to 0-10 °C, and 1 mol/L NaOH (218 mL) aqueous solution was added dropwise to the reaction kettle to adjust the pH of the reaction solution to 9-10. The layers were left to stand, and the aqueous phase was extracted with dichloromethane (0.30 L×2). The organic phases were combined and washed successively with 1 mol/L NaOH (0.10 L×1) solution and saturated brine (0.15 L×1). Activated carbon (5.0 g) was added to the organic phase to decolorize and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated, and the residue in the concentrated kettle was dissolved in acetonitrile (280 mL). Benzenesulfonic acid monohydrate (77.0 g, 0.437 mol) was prepared as a solution with purified water (280 mL) and added dropwise to the above acetonitrile solution, and the addition was completed. Program the temperature to 80-85°C, and keep the temperature for 4-6 hours. The reaction solution was cooled to 10-20° C. for crystallization for about 4-6 hours. When the internal temperature reaches 10-20°C, filter, and wash the filter cake with water (30 mL×1) and acetonitrile (50 mL×1) successively. Compound 1 was obtained after drying as a white solid (72 g, yield: 90%).

1 H NMR (400 MHz, MeOD) δ 7.83 (m, 2H), 7.42 (m, 3H), 3.31 (dt, 4H), 2.86 (m, 1H), 2.55 (d, 2H), 2.48 (ddd, 1H), 2.32 (dd, 1H), 2.15 (m, 1H), 2.04 (m, 1H), 1.77 (m, 1H), 1.62 (m, 4H), 1.45 (m, 1H), 1.28 (dt, 1H)。 1 H NMR (400 MHz, MeOD) δ 7.83 (m, 2H), 7.42 (m, 3H), 3.31 (dt, 4H), 2.86 (m, 1H), 2.55 (d, 2H), 2.48 (ddd, 1H) ), 2.32 (dd, 1H), 2.15 (m, 1H), 2.04 (m, 1H), 1.77 (m, 1H), 1.62 (m, 4H), 1.45 (m, 1H), 1.28 (dt, 1H) .

LCMS m/z =210.1[M+1]。LCMS m/z = 210.1 [M+1].

將化合物1(100mg)放置於玻璃小瓶中,加入0.2ml水和0.2ml二甲亞碸升溫至80攝氏度溶清,保持5分鐘後自然降溫至室溫,得到棒狀晶體。Compound 1 (100 mg) was placed in a glass vial, 0.2 ml of water and 0.2 ml of dimethyl sulfite were added, and the temperature was raised to 80 degrees Celsius to dissolve, kept for 5 minutes, and then cooled to room temperature naturally to obtain rod-shaped crystals.

熱台偏振光顯微鏡(PLM)和單晶繞射儀檢測(見表1), 表1檢測方法

Figure 108127452-A0304-0001
Hot stage polarized light microscope (PLM) and single crystal diffractometer detection (see Table 1), Table 1 detection method
Figure 108127452-A0304-0001

結果見表2、表3、圖1-圖3: 表2單晶結構數據

Figure 108127452-A0304-0002
表3單晶掌性解析結果
Figure 108127452-A0304-0003
The results are shown in Table 2, Table 3, Figure 1-Figure 3: Table 2 Single crystal structure data
Figure 108127452-A0304-0002
Table 3 Results of single crystal chiral analysis
Figure 108127452-A0304-0003

用上述同樣的方法,濃縮釜中剩餘物用乙腈溶解後,分別將對甲苯磺酸或甲磺酸配製成溶液,滴加到乙腈溶液中,反應完成後經後處理,分別得到下述產物:

Figure 02_image104
Figure 02_image106
實施例 2 Using the same method as above, after dissolving the residue in the concentration kettle with acetonitrile, respectively, p-toluenesulfonic acid or methanesulfonic acid is prepared into a solution, added dropwise to the acetonitrile solution, and after the reaction is completed, the following products are obtained respectively through post-processing :
Figure 02_image104
and
Figure 02_image106
. Example 2

第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)tert-butyl 2-(2-(nitromethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S ,3R,6S,8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image108
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image108

第一步:第三丁基 2-(三環[4.2.1.03,8 ]壬烷基-2-葉立德烯)乙酸酯(1R,3S,6R,8R和1S,3R,6S,8S消旋體)(1E)The first step: tertiary butyl 2-(tricyclo[4.2.1.0 3,8 ]nonyl-2-ylidene) acetate (1R,3S,6R,8R and 1S,3R,6S,8S elimination Rotary body) (1E)

tert-butyl 2-(tricyclo[4.2.1.03,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)

Figure 02_image110
tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)
Figure 02_image110

室溫下,將1,8-二氮雜二環十一碳-7-烯(288 g,1.90 mol)和二甲氧基膦醯基乙酸第三丁酯(197 g, 0.88 mol)到反應瓶中,加畢繼續攪拌20分鐘。再將1D (100 g, 0.73 mol)加到反應夜中,加畢。升溫到40℃反應6小時。得到黃色液體,直接進行下一步反應1E (172 g)。1,8-Diazabicycloundec-7-ene (288 g, 1.90 mol) and tert-butyl dimethoxyphosphonoacetate (197 g, 0.88 mol) were added to the reaction at room temperature bottle, add and continue to stir for 20 minutes. 1D (100 g, 0.73 mol) was added to the reaction overnight and the addition was complete. The temperature was raised to 40°C for 6 hours. A yellow liquid was obtained, which was carried directly to the next reaction 1E (172 g).

LCMS m/z =257.1 [M+23]。LCMS m/z = 257.1 [M+23].

第二步:第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)The second step: tertiary butyl 2-(2-(nitromethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (1R,2R,3S,6R,8R and 1S, 2S, 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image112
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image112

向2L反應釜依次加入1E 反應液(172 g, 0.73mol),硝基甲烷(224 g, 3.67 mol),1,8-二氮雜二環十一碳-7-烯(134 g,0.88 mol)和二甲基亞碸(500 mL)。加熱到80℃-85℃,繼續保溫反應5小時。冷卻到室溫,向反應釜加入純化水(2.0 L),水相用甲基第三丁基醚(800 mL×3)萃取。合併有機相,用飽和食鹽水(800 mL×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到棕色液體1F ( 193g,產率:90%)。 1E reaction solution (172 g, 0.73 mol), nitromethane (224 g, 3.67 mol), 1,8-diazabicycloundec-7-ene (134 g, 0.88 mol) were successively added to the 2L reactor ) and dimethylsulfoxide (500 mL). Heated to 80°C-85°C, and the reaction was continued for 5 hours. After cooling to room temperature, purified water (2.0 L) was added to the reaction kettle, and the aqueous phase was extracted with methyl tert-butyl ether (800 mL×3). The organic phases were combined, washed with saturated brine (800 mL×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave brown liquid IF (193 g, yield: 90%).

LCMS m/z =318.1 [M+23]。實施例 3 LCMS m/z = 318.1 [M+23]. Example 3

第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)tert-butyl 2-(2-(nitromethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S ,3R,6S,8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image108
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image108

第一步:第三丁基 2-(三環[4.2.1.03,8 ]壬烷基-2-葉立德烯)乙酸酯(1R,3S,6R,8R和1S,3R,6S,8S消旋體)(1E)The first step: tertiary butyl 2-(tricyclo[4.2.1.0 3,8 ]nonyl-2-ylidene) acetate (1R,3S,6R,8R and 1S,3R,6S,8S elimination Rotary body) (1E)

tert-butyl 2-(tricyclo[4.2.1.03,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)

Figure 02_image110
tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8Rand 1S,3R,6S,8S racemate)
Figure 02_image110

將第三丁醇鉀(9.06 g, 80.76 mmol)和四氫呋喃(150 mL) 加入1L反應釜中。降溫到5℃,滴加二甲氧基膦醯基乙酸第三丁酯(18.11 g,80.76 mmol, 1.1eq)到反應液中,控制反應溫度10℃-15℃,約20分鐘滴加完畢。繼續攪拌0.5小時,控溫10℃-15℃。再將1D (10.0 g, 73.42 mmol, 1.0 eq)的四氫呋喃(50.0 mL)溶液滴加到反應液,0.5小時內滴加完,加畢自然升到室溫反應2小時。向反應釜依次加入飽和氯化銨(100.0 mL),純化水(100.0 mL)淬滅反應。攪拌20分鐘後靜置分層,水相用甲基第三丁基醚(50.0 mL×1)萃取。合併有機相,用飽和食鹽水(100.0 mL×1)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到黃色液體1E (17.5g)。Potassium tertiary butoxide (9.06 g, 80.76 mmol) and tetrahydrofuran (150 mL) were added to a 1 L reaction kettle. The temperature was lowered to 5°C, and tert-butyl dimethoxyphosphonoacetate (18.11 g, 80.76 mmol, 1.1 eq) was added dropwise to the reaction solution, and the reaction temperature was controlled to 10°C-15°C, and the dropwise addition was completed in about 20 minutes. Continue stirring for 0.5 hours, and control the temperature to 10°C-15°C. Then, a solution of 1D (10.0 g, 73.42 mmol, 1.0 eq) in tetrahydrofuran (50.0 mL) was added dropwise to the reaction solution, the dropwise addition was completed within 0.5 hours, and the reaction was naturally raised to room temperature for 2 hours. Saturated ammonium chloride (100.0 mL) was sequentially added to the reaction kettle, and purified water (100.0 mL) was quenched. After stirring for 20 minutes, the mixture was left to stand for layers, and the aqueous phase was extracted with methyl tert-butyl ether (50.0 mL×1). The organic phases were combined, washed with saturated brine (100.0 mL×1), and dried over anhydrous sodium sulfate. Filtration and concentration gave yellow liquid 1E (17.5 g).

LCMS m/z =257.1[M+23]。LCMS m/z = 257.1 [M+23].

第二步:第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)The second step: tertiary butyl 2-(2-(nitromethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (1R,2R,3S,6R,8R and 1S, 2S, 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image112
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image112

向250 mL反應瓶依次加入1E (16.5 g, 70.41 mmol, 1.0 eq),硝基甲烷(24.49 g, 0.35 mol, 5.0 eq)和二甲基亞碸(116 mL)。再將第三丁醇鉀 (15.8 g, 0.14 mol, 2.0 eq)加到反應液中。加畢,加熱到80℃-85℃,繼續保溫反應8小時。冷卻到室溫,向反應釜加入純化水(450 mL),水相用甲基第三丁基醚(150 mL×3)萃取。合併有機相,用飽和食鹽水(150 mL×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到棕色液體1F (20.8 g)。To a 250 mL reaction flask were added 1E (16.5 g, 70.41 mmol, 1.0 eq), nitromethane (24.49 g, 0.35 mol, 5.0 eq) and dimethylsulfite (116 mL) sequentially. Then potassium tertiary butoxide (15.8 g, 0.14 mol, 2.0 eq) was added to the reaction solution. After the addition was completed, the mixture was heated to 80°C-85°C, and the reaction was continued for 8 hours. After cooling to room temperature, purified water (450 mL) was added to the reaction kettle, and the aqueous phase was extracted with methyl tert-butyl ether (150 mL×3). The organic phases were combined, washed with saturated brine (150 mL×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave a brown liquid 1F (20.8 g).

LCMS m/z =318.1 [M+23]。實施例 4 LCMS m/z = 318.1 [M+23]. Example 4

第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)tert-butyl 2-(2-(nitromethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S ,3R,6S,8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image108
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image108

第一步:第三丁基 2-(三環[4.2.1.03,8 ]壬烷基-2-葉立德烯)乙酸酯(1R,3S,6R,8R和1S,3R,6S,8S消旋體)(1E)The first step: tertiary butyl 2-(tricyclo[4.2.1.0 3,8 ]nonyl-2-ylidene) acetate (1R,3S,6R,8R and 1S,3R,6S,8S elimination Rotary body) (1E)

tert-butyl 2-(tricyclo[4.2.1.03,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8R and 1S,3R,6S,8S racemate)

Figure 02_image110
tert-butyl 2-(tricyclo[4.2.1.0 3,8 ]nonan-2-ylidene)acetate (1R,3S,6R,8R and 1S,3R,6S,8S racemate)
Figure 02_image110

將第三丁醇鉀(1.23 kg,11.0 mol)和四氫呋喃(10.0L) 加入50L反應釜中。降溫到5℃,滴加二甲氧基膦醯基乙酸第三丁酯(2.50 kg, 11.0 mol, 1.1eq)到反應液中,控制反應溫度10℃-15℃,約40分鐘滴加完畢。繼續攪拌0.5小時,控溫10℃-15℃。再將1D (1.36 kg, 10.0mol, 1.0 eq)的四氫呋喃(3.60 L)溶液滴加到反應液,0.5小時內滴加完。加畢自然升到室溫反應2小時。中控檢測原料反應完全後,向反應釜依次加入5%氯化銨溶液(6.0 L)淬滅反應。攪拌20分鐘後靜置分層,水相用二氯甲烷(5.0L×1)萃取。合併有機相,用5%食鹽水(5.0L×1)洗滌,無水硫酸鈉乾燥。過濾,濃縮,得到黃色液體1E (2.40 kg)。Potassium tertiary butoxide (1.23 kg, 11.0 mol) and tetrahydrofuran (10.0 L) were added to a 50 L reaction kettle. The temperature was lowered to 5°C, and tert-butyl dimethoxyphosphonoacetate (2.50 kg, 11.0 mol, 1.1 eq) was added dropwise to the reaction solution, and the reaction temperature was controlled to 10°C-15°C, and the dropwise addition was completed in about 40 minutes. Continue stirring for 0.5 hours, and control the temperature to 10°C-15°C. Then, a solution of 1D (1.36 kg, 10.0 mol, 1.0 eq) in tetrahydrofuran (3.60 L) was added dropwise to the reaction solution, and the dropwise addition was completed within 0.5 hour. After the addition was completed, the reaction was naturally raised to room temperature for 2 hours. After the complete reaction of the raw materials detected by the central control, 5% ammonium chloride solution (6.0 L) was sequentially added to the reaction kettle to quench the reaction. After stirring for 20 minutes, the mixture was left to stand for layers, and the aqueous phase was extracted with dichloromethane (5.0 L×1). The organic phases were combined, washed with 5% brine (5.0L×1), and dried over anhydrous sodium sulfate. Filtration and concentration gave a yellow liquid 1E (2.40 kg).

LCMS m/z =257.1[M+23]。LCMS m/z = 257.1 [M+23].

第二步:第三丁基 2-(2-(硝基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R和1S,2S,3R,6S,8S消旋體)(1F)The second step: tertiary butyl 2-(2-(nitromethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (1R,2R,3S,6R,8R and 1S, 2S, 3R, 6S, 8S racemate) (1F)

tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image112
tert-butyl 2-(2-(nitromethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)
Figure 02_image112

向50L反應釜依次加入1E (2.34 kg, 10.0mol, 1.0 eq),硝基甲烷(1.53kg, 25.0mol, 2.5eq)和二甲基亞碸(2.34L)。開啟攪拌,再將第三丁醇鉀 (15.8 g, 0.14 mol, 2.0 eq)加到反應液中。加畢,加熱到85℃-90℃,繼續保溫反應10小時。中控,原料小於2%時,冷卻到25℃,向反應釜加入純化水(8.50L),水相用二氯甲烷(3.50L×3)萃取。合併有機相,依次用 0.5mol/L鹽酸溶液(2.0L×1) ,0.5mol/L氫氧化鈉溶液(2.0L×1) 和5%氯化鈉溶液(2.0L×1)洗滌。過濾,將濾液控溫在35±5℃以下減壓濃縮至無大量餾分流出。升溫至55±5℃繼續減壓蒸除硝基甲烷,取樣中控,控制硝基甲烷含量小於5%。得到棕色液體1F (2.95kg)。 1E (2.34 kg, 10.0 mol, 1.0 eq), nitromethane (1.53 kg, 25.0 mol, 2.5 eq) and dimethylsulfite (2.34 L) were successively added to the 50 L reactor. Turn on stirring, and then add potassium tertiary butoxide (15.8 g, 0.14 mol, 2.0 eq) to the reaction solution. After the addition was completed, the mixture was heated to 85°C-90°C, and the reaction was continued for 10 hours. In the control, when the raw material is less than 2%, cool to 25°C, add purified water (8.50L) to the reaction kettle, and extract the aqueous phase with dichloromethane (3.50L×3). The organic phases were combined and washed successively with 0.5mol/L hydrochloric acid solution (2.0L×1), 0.5mol/L sodium hydroxide solution (2.0L×1) and 5% sodium chloride solution (2.0L×1). Filter, control the temperature of the filtrate and concentrate under reduced pressure below 35±5°C until no large amount of distillate flows out. The temperature was raised to 55±5°C, and the nitromethane was evaporated under reduced pressure. The sampling was controlled in the middle, and the content of nitromethane was controlled to be less than 5%. A brown liquid 1F (2.95 kg) was obtained.

LCMS m/z =318.1 [M+23]。實施例 5 LCMS m/z = 318.1 [M+23]. Example 5

第三丁基2-(2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R與1S,2S,3R,6S,8S的消旋體) 2A tert-butyl 2-(2-(aminomethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S ,3R,6S,8S racemate) ( 2A )

tert-butyl2-((1R,2R,3S,6R,8R)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate(1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image116
tert-butyl2-((1R,2R,3S,6R,8R)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate(1R,2R,3S,6R,8R and 1S ,2S,3R,6S,8S racemate)
Figure 02_image116

向反應瓶中依次加入1F (90 g, 0.31 mol),甲醇 (900 mL),鈀碳10% (9.0g),氫氣換氣三次,室溫下氫化反應16小時。將反應液過濾,濾液減壓濃縮,得到黃色液體2A (73.5 g, 產率:91%)。 1F (90 g, 0.31 mol), methanol (900 mL), palladium carbon 10% (9.0 g) were successively added to the reaction flask, the hydrogen was purged three times, and the hydrogenation reaction was carried out at room temperature for 16 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure to obtain a yellow liquid 2A (73.5 g, yield: 91%).

Ms m/z (ESI): 266.1(M+1)。實施例 6 Ms m/z (ESI): 266.1(M+1). Example 6

第三丁基2-(2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(1R,2R,3S,6R,8R與1S,2S,3R,6S,8S的消旋體) 2A tert-butyl 2-(2-(aminomethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (1R,2R,3S,6R,8R and 1S,2S ,3R,6S,8S racemate) ( 2A )

tert-butyl2-((1R,2R,3S,6R,8R)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetate(1R,2R,3S,6R,8R and 1S,2S,3R,6S,8S racemate)

Figure 02_image118
tert-butyl2-((1R,2R,3S,6R,8R)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetate(1R,2R,3S,6R,8R and 1S ,2S,3R,6S,8S racemate)
Figure 02_image118

向反應瓶中加入1F (70 g, 0.24 mol),乙醇 (360 mL)和水 (120mL),依次加入鐵粉 (67.2 g,1.2 mol) 和氯化銨 ( 38.5 g,0.72 mol),加畢於90℃反應4小時。將反應液過濾,濾液減壓濃縮後加入純化水(450 mL),水相用二氯甲烷(150 mL×3)萃取。合併有機相,用飽和食鹽水(150 mL×2)洗滌,無水硫酸鈉乾燥。過濾,濃縮得到黃色液體2A (55 g, 產率:88%)。 1F (70 g, 0.24 mol), ethanol (360 mL) and water (120 mL) were added to the reaction flask, followed by iron powder (67.2 g, 1.2 mol) and ammonium chloride (38.5 g, 0.72 mol), and the addition was completed. The reaction was carried out at 90°C for 4 hours. The reaction solution was filtered, the filtrate was concentrated under reduced pressure, purified water (450 mL) was added, and the aqueous phase was extracted with dichloromethane (150 mL×3). The organic phases were combined, washed with saturated brine (150 mL×2), and dried over anhydrous sodium sulfate. Filtration and concentration gave yellow liquid 2A (55 g, yield: 88%).

Ms m/z (ESI):266.1(M+1)。實施例 7 Ms m/z (ESI): 266.1 (M+1). Example 7

第三丁基2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸酯(S)-2-乙醯氧基-2苯乙酸(1H)重結晶tert-butyl 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[ 4.2.1.03,8 ]nonyl-2-yl)acetate (S )-2-Acetyloxy-2phenylacetic acid (1H) recrystallization

tert-butyl2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (S)-2-acetoxy-2-phenylacetate

Figure 02_image100
tert-butyl2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetate (S)-2-acetoxy-2-phenylacetate
Figure 02_image100

方法一:method one:

將粗產品1H (80.0 g, 0.17mol),異丙醇(750 mL)和水(50 mL,v:v=15:1)依次加入反應瓶中。升溫使固體完全溶解,保溫0.5小時。降溫至20℃析晶,過濾,濾餅用異丙醇(0.40 L×1)洗滌,60-65℃乾燥4小時。得1H 第一次重結晶產品60 g,產率:75%),取固體衍生後測定ee值為97.22%。The crude product 1H (80.0 g, 0.17 mol), isopropanol (750 mL) and water (50 mL, v:v=15:1) were sequentially added to the reaction flask. The temperature was raised to completely dissolve the solid, and the temperature was maintained for 0.5 hours. Cool to 20°C for crystallization, filter, wash the filter cake with isopropanol (0.40 L×1), and dry at 60-65°C for 4 hours. 60 g of 1H recrystallized product was obtained for the first time, yield: 75%), and the ee value was determined to be 97.22% after the solid was derivatized.

第二次重結晶:將1H 第一次重結晶產品(137 g, 0.30 mol),異丙醇(1284 mL)和水(85.6mL,v:v=15:1)依次加入反應釜中。升溫使固體完全溶解,保溫0.5小時。降溫至20℃析晶,過濾,濾餅用異丙醇(0.10 L×1)洗滌,60-65℃乾燥。得白色固體1H 第二次重結晶產品 (112g,產率:82%),取固體衍生後測定ee值為99.72%。The second recrystallization: The first recrystallization product of 1H (137 g, 0.30 mol), isopropanol (1284 mL) and water (85.6 mL, v:v=15:1) were sequentially added to the reaction kettle. The temperature was raised to completely dissolve the solid, and the temperature was maintained for 0.5 hours. Cool to 20°C for crystallization, filter, wash the filter cake with isopropanol (0.10 L×1), and dry at 60-65°C. A white solid 1H recrystallized product (112 g, yield: 82%) was obtained for the second time , and the ee value was determined to be 99.72% after derivatization of the solid.

LCMS m/z =266.3 [M+1]。LCMS m/z = 266.3 [M+1].

方法二:Method Two:

第二次重結晶:將1H 第一次重結晶產品(10.0g, 21.76 mmol,ee%=77%),異丙醇和水(290mL/10mL,v:v=29:1)依次加入反應瓶中。升溫使固體完全溶解,保溫0.5小時。降溫至30℃析晶,過濾,濾餅用異丙醇(10.0m L×1)洗滌。合併固體,60-65℃乾燥。得白色固體1H 第二次重結晶產品 (6.1 g,產率:61%),取固體衍生後測定ee值為97.3%。The second recrystallization: the first recrystallization product of 1H (10.0g, 21.76 mmol, ee%=77%), isopropanol and water (290mL/10mL, v:v=29:1) were added to the reaction flask in turn . The temperature was raised to completely dissolve the solid, and the temperature was maintained for 0.5 hours. Cool to 30°C for crystallization, filter, and wash the filter cake with isopropanol (10.0 mL × 1). The solids were combined and dried at 60-65°C. The second recrystallization product (6.1 g, yield: 61%) of 1H was obtained as a white solid, and the ee value was determined to be 97.3% after derivatization of the solid.

LCMS m/z =266.3 [M+1]。實施例 8 LCMS m/z = 266.3 [M+1]. Example 8

2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸苯磺酸鹽 (1:1)(化合物1)2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid benzenesulfonate (1:1 ) (compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image119
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image119

1H (10.0 g,21.77mol)和純化水(100.0 mL)依次加入反應瓶中。降溫到0-10℃。內溫至0-10 ℃時,滴加25%氨水溶液(4.0 mL)到反應液中,調節反應液pH至9-10。靜置分層,水相用乙酸異丙酯(50.0 mL×2)萃取。合併有機相,用飽和食鹽水(50.0 mL×1)洗滌。有機相中加入活性炭(0.5 g)脫色,無水硫酸鈉乾燥。過濾,濾液加入苯磺酸一水合物(8.06 g,43.54 mmol),加畢。加熱升溫至80-85℃。保溫反應4-6小時,中控檢測原料反應完全。冰水降溫至20-25℃析晶,約2小時。內溫至20-25℃時,過濾,濾餅用乙酸異丙酯(10 mL×1)洗滌。乾燥後得到白色固體化合物 1 (7.8g,產率:97.6%)。實施例 9 1H (10.0 g, 21.77 mol) and purified water (100.0 mL) were sequentially added to the reaction flask. Cool down to 0-10°C. When the internal temperature reached 0-10 °C, 25% aqueous ammonia solution (4.0 mL) was added dropwise to the reaction solution, and the pH of the reaction solution was adjusted to 9-10. The layers were left to stand, and the aqueous phase was extracted with isopropyl acetate (50.0 mL×2). The organic phases were combined and washed with saturated brine (50.0 mL×1). Activated carbon (0.5 g) was added to the organic phase to decolorize and dried over anhydrous sodium sulfate. Filter, add benzenesulfonic acid monohydrate (8.06 g, 43.54 mmol) to the filtrate and finish the addition. Heat up to 80-85°C. Incubate the reaction for 4-6 hours, and the central control detects that the reaction of the raw materials is complete. Cool the ice water to 20-25°C for crystallization, about 2 hours. When the internal temperature reaches 20-25°C, filter, and wash the filter cake with isopropyl acetate (10 mL×1). Compound 1 (7.8 g, yield: 97.6%) was obtained as a white solid after drying. Example 9

2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸苯磺酸化合物 (1:1)(化合物1)2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid benzenesulfonic acid compound (1:1 ) (compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image121
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image121

1H (4.59 g,10.0 mmol)和純化水(40.0 mL)依次加入反應瓶中。降溫到0-10℃。內溫至0-10 ℃時,滴加1.0mol/L氫氧化鈉溶液(11.0 mL)到反應液中,調節反應液pH至9-10。靜置分層,水相用二氯甲烷(25.0 mL×2)萃取。合併有機相,依次用0.5 mol/L氫氧化鈉溶液(20.0 mL×1)和飽和食鹽水(25.0 mL×1)洗滌。有機相中加入活性炭(0.5 g)脫色,無水硫酸鈉乾燥。過濾,濾液濃縮後加入乙腈(26.0 mL)和苯磺酸一水合物(3.50 g,20.0 mmol),加畢。加熱升溫至80℃。保溫反應4-6小時,中控檢測原料反應完全。冰水降溫至25℃析晶,約2小時。內溫至25℃時,過濾,濾餅用乙腈(3.0 mL×2)洗滌。乾燥後得到白色固體化合物 1 (3.4 g,產率:92.6%)。實施例 10 1H (4.59 g, 10.0 mmol) and purified water (40.0 mL) were sequentially added to the reaction flask. Cool down to 0-10°C. When the internal temperature reached 0-10 °C, 1.0 mol/L sodium hydroxide solution (11.0 mL) was added dropwise to the reaction solution, and the pH of the reaction solution was adjusted to 9-10. The layers were left to stand, and the aqueous phase was extracted with dichloromethane (25.0 mL×2). The organic phases were combined and washed successively with 0.5 mol/L sodium hydroxide solution (20.0 mL×1) and saturated brine (25.0 mL×1). Activated carbon (0.5 g) was added to the organic phase to decolorize and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated, and acetonitrile (26.0 mL) and benzenesulfonic acid monohydrate (3.50 g, 20.0 mmol) were added, and the addition was completed. Heating to 80°C. Incubate the reaction for 4-6 hours, and the central control detects that the reaction of the raw materials is complete. The ice water was cooled to 25°C for crystallization for about 2 hours. When the internal temperature reaches 25°C, filter, and wash the filter cake with acetonitrile (3.0 mL×2). Compound 1 (3.4 g, yield: 92.6%) was obtained as a white solid after drying. Example 10

2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸苯磺酸鹽(1:1)(化合物1)2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid benzenesulfonate (1:1 ) (compound 1)

2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)

Figure 02_image122
2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid compound with benzenesulfonic acid (1:1)
Figure 02_image122

1H (150 g,0.33mol)和純化水(1500 mL)依次加入反應瓶中。降溫到0-10℃,滴加1.0mol/L氫氧化鈉溶液(360 mL)到反應液中,調節反應液pH至9-10並攪拌1小時。靜置分層,水相用二氯甲烷(800 mL×2)萃取。合併有機相,依次用1.0mol/L氫氧化鈉溶液(300.0 mL×1)和10%食鹽水(300.0 mL×1)洗滌。有機相中加入活性炭(5.0 g)攪拌脫色。矽藻土過濾,濾液濃縮後加入乙腈(328.0 mL),純化水(328.0 mL)和苯磺酸一水合物(114g,0.66mol),加畢。加熱升溫至80℃。保溫反應12小時,中控檢測原料小於0.2%反應完全。冰水降溫至10±5℃,攪拌約6小時析晶。內溫至10℃時,過濾,濾餅依次用乙腈和水(V:V=1:1,150 mL×1),二氯甲烷(150 mL×1)洗滌,抽乾。固體減壓乾燥得到白色固體化合物 1 (104 g,產率:86.9%)。 1H (150 g, 0.33 mol) and purified water (1500 mL) were added to the reaction flask sequentially. The temperature was lowered to 0-10°C, 1.0 mol/L sodium hydroxide solution (360 mL) was added dropwise to the reaction solution, the pH of the reaction solution was adjusted to 9-10 and stirred for 1 hour. The layers were left to stand, and the aqueous phase was extracted with dichloromethane (800 mL×2). The organic phases were combined and washed successively with 1.0 mol/L sodium hydroxide solution (300.0 mL×1) and 10% brine (300.0 mL×1). Activated carbon (5.0 g) was added to the organic phase and stirred for decolorization. Celite was filtered, the filtrate was concentrated, and acetonitrile (328.0 mL), purified water (328.0 mL) and benzenesulfonic acid monohydrate (114 g, 0.66 mol) were added, and the addition was completed. Heating to 80°C. Incubate the reaction for 12 hours, and the central control detects that less than 0.2% of the raw material reacts completely. The ice water was cooled to 10±5°C, and the mixture was stirred for about 6 hours to crystallize. When the internal temperature reaches 10°C, filter, and the filter cake is washed successively with acetonitrile, water (V:V=1:1, 150 mL×1), dichloromethane (150 mL×1), and drained. The solid was dried under reduced pressure to obtain compound 1 as a white solid (104 g, yield: 86.9%).

化合物1可以進一步通過以下方法精製:Compound 1 can be further purified by the following methods:

方法1:化合物 1 (430.0g, 1.17mol)和N-甲基吡咯烷酮(2.15L)加入5L反應瓶。加畢,加熱至80±5℃並保溫0.5小時。待固體完全溶解後,加入活性炭(10g)繼續攪拌10分鐘。趁熱過濾,濾餅用N-甲基吡咯烷酮(400mL×1)洗滌,抽乾。濾液滴加乙酸異丙酯(7.5L),加畢,繼續攪拌析晶2小時。過濾,濾餅用乙酸異丙酯(500.0 mL)洗滌,抽乾,減壓乾燥8小時,得到白色固體化合物 1 (420.0 g,產率:97.7%)。Method 1: Compound 1 (430.0 g, 1.17 mol) and N-methylpyrrolidone (2.15 L) were added to a 5 L reaction flask. After adding, heat to 80±5℃ and keep for 0.5 hours. After the solid was completely dissolved, activated carbon (10 g) was added and stirring was continued for 10 minutes. Filter while hot, and the filter cake is washed with N-methylpyrrolidone (400 mL×1) and dried by suction. Isopropyl acetate (7.5 L) was added dropwise to the filtrate, and after the addition was completed, stirring and crystallization were continued for 2 hours. After filtration, the filter cake was washed with isopropyl acetate (500.0 mL), dried by suction, and dried under reduced pressure for 8 hours to obtain compound 1 (420.0 g, yield: 97.7%) as a white solid.

方法2:化合物 1 (410g,1.12mol)和二甲亞碸(1230 mL)加入5L反應瓶。加畢,加熱至50±5℃並保溫0.5小時。待固體完全溶解後,加入滴加純化水(2460 mL),加畢,水浴降溫至15℃繼續攪拌析晶2小時。過濾,濾餅依次用純化水(400.0 mL×1),二氯甲烷(400.0 mL×2)洗滌,抽乾,減壓乾燥得到白色固體化合物 1 (352 g,產率:85.8%)。實施例 11 Method 2: Compound 1 (410 g, 1.12 mol) and dimethyl sulfite (1230 mL) were added to a 5L reaction flask. After adding, heat to 50±5℃ and keep for 0.5 hours. After the solid was completely dissolved, purified water (2460 mL) was added dropwise, and after the addition was completed, the temperature was lowered to 15°C in a water bath and continued to stir and crystallize for 2 hours. After filtration, the filter cake was washed successively with purified water (400.0 mL×1) and dichloromethane (400.0 mL×2), suction-dried, and dried under reduced pressure to obtain compound 1 (352 g, yield: 85.8%) as a white solid. Example 11

(S)-2-羥基-2-苯乙酸 2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸(1:1)(化合物2)(S)-2-Hydroxy-2-phenylacetic acid 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2 -yl)acetic acid (1:1) (compound 2)

(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid (1:1)

Figure 02_image123
Figure 02_image125
(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid (1:1)
Figure 02_image123
Figure 02_image125

第一步:2-(2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸(1R,2R,3S,6R,8R與1S,2S,3R,6S,8S的消旋體)(2B)The first step: 2-(2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2-yl)acetic acid (1R,2R,3S,6R,8R and 1S,2S,3R ,6S,8S racemate) (2B)

2-(2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetic acid (1R,2R,3S,6R,8Rand 1S,2S,3R,6S,8S racemate)

Figure 02_image127
2-(2-(aminomethyl)tricyclo[4.2.1.03,8]nonan-2-yl)acetic acid (1R,2R,3S,6R,8Rand 1S,2S,3R,6S,8S racemate)
Figure 02_image127

向反應瓶中依次加入2A (44.45 g, 0.17mol)和二氯甲烷(150.0 mL)。攪拌並降溫到0℃-5℃,將三氟乙酸(60.0 mL)滴加到反應液中。加畢於0℃-10℃反應6小時,TLC監控原料完全轉化,將反應液濃縮除去溶劑。剩餘物加入二氯甲烷(150.0 mL),降溫到0℃-5℃。用三乙胺(60.0 mL)調節pH至7-8,析出白色 固體並攪拌1小時。過濾,濾餅用二氯甲烷(50.0 mL)洗滌,合併固體乾燥得到白色固體2B (22.0 g,產率:68.4%)。To the reaction flask was added 2A (44.45 g, 0.17 mol) followed by dichloromethane (150.0 mL). After stirring and cooling to 0°C-5°C, trifluoroacetic acid (60.0 mL) was added dropwise to the reaction solution. After the addition was completed, the reaction was carried out at 0°C to 10°C for 6 hours. TLC monitored the complete conversion of the raw materials, and the reaction solution was concentrated to remove the solvent. Dichloromethane (150.0 mL) was added to the residue, and the temperature was lowered to 0°C-5°C. The pH was adjusted to 7-8 with triethylamine (60.0 mL) and a white solid precipitated and was stirred for 1 hour. After filtration, the filter cake was washed with dichloromethane (50.0 mL), and the combined solids were dried to give white solid 2B (22.0 g, yield: 68.4%).

LCMS m/z =210.1 [M+1]。LCMS m/z = 210.1 [M+1].

第二步:(S)-2-羥基-2-苯乙酸 2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸(1:1)(化合物2)The second step: (S)-2-hydroxy-2-phenylacetic acid 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[ 4.2.1.03,8 ]nonane Alkyl-2-yl)acetic acid (1:1) (compound 2)

(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid (1:1)

Figure 02_image129
(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid (1:1)
Figure 02_image129

向100mL反應瓶中依次加入2B (6.32 g,30.0 mmol),L-扁桃酸(8.86 g,45.0 mmol),異丙醇(62.0 mL)和水(12.4 mL)。加畢,加熱升溫至82℃,使固體完全溶解,保溫0.5小時後自然降溫至20℃析晶,約6小時。內溫至20℃時,過濾,濾餅用異丙醇(5.0 mL×2)洗滌。固體乾燥1小時,得到白色固體(3.2 g,產率:24.2%)。To a 100 mL reaction flask were added 2B (6.32 g, 30.0 mmol), L-mandelic acid (8.86 g, 45.0 mmol), isopropanol (62.0 mL) and water (12.4 mL) sequentially. After the addition is completed, the temperature is heated to 82° C. to completely dissolve the solid, and the temperature is naturally lowered to 20° C. for crystallization after being kept for 0.5 hours for about 6 hours. When the internal temperature reached 20 °C, filter, and wash the filter cake with isopropanol (5.0 mL×2). The solid was dried for 1 hour to give a white solid (3.2 g, yield: 24.2%).

第一次結晶:將白色固體鹽(3.2 g),異丙醇(32 mL)和水(5.2mL)依次加入100mL反應瓶中。加熱,程序升溫至82℃,使固體完全溶解,保溫0.5小時後降溫至20℃析晶,約6小時。內溫至20℃時,過濾,濾餅用異丙醇(5.0 mL×2)洗滌。合併固體,乾燥1小時,得到第一次結晶物(2.0 g,產率:62.5%),衍生後測定ee值為53%。The first crystallization: white solid salt (3.2 g), isopropanol (32 mL) and water (5.2 mL) were sequentially added to a 100 mL reaction flask. Heating, program the temperature to 82° C. to completely dissolve the solid, and keep the temperature for 0.5 hours, then lower the temperature to 20° C. for crystallization, for about 6 hours. When the internal temperature reached 20 °C, filter, and wash the filter cake with isopropanol (5.0 mL×2). The solids were combined and dried for 1 hour to obtain the first crystal (2.0 g, yield: 62.5%), and the ee value after derivatization was determined to be 53%.

第二次結晶:將第一次結晶物(1.0 g),乙醇(16.0 mL)和水(1.3mL)依次加入100mL反應瓶中。加熱升溫至82℃,使固體完全溶解,保溫0.5小時後降溫至20℃析晶,約4.5小時。內溫至30℃時,過濾,濾餅用乙醇(1.0 mL×2)洗滌。合併固體,乾燥1小時,烘乾至恆重,得到化合物 2 (0.63 g,收率63%),衍生後測定ee值為72%。

Figure 02_image130
The second crystallization: the first crystallization (1.0 g), ethanol (16.0 mL) and water (1.3 mL) were added to the 100 mL reaction flask in sequence. The temperature was heated to 82°C to completely dissolve the solid, and the temperature was lowered to 20°C for about 4.5 hours after the temperature was maintained for 0.5 hours. When the internal temperature reaches 30 °C, filter, and wash the filter cake with ethanol (1.0 mL×2). The solids were combined, dried for 1 hour, and dried to constant weight to obtain compound 2 (0.63 g, yield 63%), and the ee value was determined to be 72% after derivatization.
Figure 02_image130

將化合物2用實施例1類似方法,製備得到化合物1。實施例 12 Compound 2 was prepared in a similar manner to Example 1 to obtain compound 1. Example 12

3-(環己基-3-烯-1-基)-1-(吡咯烷基-1-基)丙基-1-酮(1C)3-(Cyclohexyl-3-en-1-yl)-1-(pyrrolidin-1-yl)propyl-1-one (1C)

3-(cyclohex-3-en-1-yl)-1-(pyrrolidin-1-yl)propan-1-one

Figure 02_image132
3-(cyclohex-3-en-1-yl)-1-(pyrrolidin-1-yl)propan-1-one
Figure 02_image132

將3-環己烯-1-丙酸(4.11 kg,26.68 mol,1eq)用二氯甲烷(20.0 L)溶解後加入50L反應釜中,加畢。降溫至20℃,加入三乙胺(4.04 Kg,40.03 mol,1.5eq)。再依次加入1-羥基苯並三唑(4.32 kg,32.02 mol,1.2eq), 1-乙基-(3-二甲基胺基丙基)碳醯二亞胺鹽酸鹽(6.11 kg,32.02 mol,1.2eq) ,加畢攪拌30分鐘。降溫到0℃時滴加四氫吡咯(2.46 kg,34.69mol,1.3eq),加畢,於室溫攪拌過夜。反應液用純化水(15.0 L×2),2.0 mol/L鹽酸(15.0 L×3)洗滌。有機相用無水硫酸鈉(2.0 kg)乾燥,過濾,濾液濃縮蒸乾得棕色油狀物1C (6.60 kg)。The 3-cyclohexene-1-propionic acid (4.11 kg, 26.68 mol, 1 eq) was dissolved in dichloromethane (20.0 L) and added to a 50 L reaction kettle, and the addition was completed. The temperature was lowered to 20°C, and triethylamine (4.04 Kg, 40.03 mol, 1.5 eq) was added. Then 1-hydroxybenzotriazole (4.32 kg, 32.02 mol, 1.2eq), 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (6.11 kg, 32.02 mol, 1.2eq), added and stirred for 30 minutes. When the temperature was lowered to 0 °C, tetrahydropyrrole (2.46 kg, 34.69 mol, 1.3 eq) was added dropwise, the addition was completed, and the mixture was stirred at room temperature overnight. The reaction solution was washed with purified water (15.0 L×2) and 2.0 mol/L hydrochloric acid (15.0 L×3). The organic phase was dried with anhydrous sodium sulfate (2.0 kg), filtered, and the filtrate was concentrated and evaporated to dryness to obtain a brown oily substance 1C (6.60 kg).

1 H NMR (400 MHz, CDCl3 ) δ 5.73 – 5.56 (m, 2H), 3.43 (dd, 4H), 2.37 – 2.22 (m, 2H), 2.16 – 2.01 (m, 4H), 1.90 (dt, 4H), 1.81 – 1.51 (m, 6H), 1.30 – 1.15 (m, 2H)。 1 H NMR (400 MHz, CDCl 3 ) δ 5.73 – 5.56 (m, 2H), 3.43 (dd, 4H), 2.37 – 2.22 (m, 2H), 2.16 – 2.01 (m, 4H), 1.90 (dt, 4H) ), 1.81 – 1.51 (m, 6H), 1.30 – 1.15 (m, 2H).

LCMS m/z =208.1 [M+1]。實施例 13 LCMS m/z = 208.1 [M+1]. Example 13

(R)-2-羥基-2-苯乙酸 2-((1S,2S,3R,6S,8S)-2-(胺基甲基)三環[4.2.1.03,8 ]壬烷基-2-基)乙酸(1:1)(化合物2)(R)-2-Hydroxy-2-phenylacetic acid 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonyl-2 -yl)acetic acid (1:1) (compound 2)

(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.03,8 ]nonan-2-yl)acetic acid (1:1)

Figure 02_image134
(S)-2-hydroxy-2-phenylacetic acid compound with 2-((1S,2S,3R,6S,8S)-2-(aminomethyl)tricyclo[4.2.1.0 3,8 ]nonan-2-yl)acetic acid (1:1)
Figure 02_image134

2A (1.0 g, 3.77 mmol)用乙腈(25.0 mL)溶解後。將D-扁桃酸(286.0 mg,1.89 mmol ,0.5 eq)溶解乙腈(5 mL)滴加到反應中,加畢室溫攪拌4小時。過濾,濾餅用乙腈(2.0 mL×1)洗滌,烘乾得到白色固體化合物 3 粗品 ( 0.48g,產率:37%)。取固體衍生後測定ee值為41.9%。 2A (1.0 g, 3.77 mmol) was dissolved in acetonitrile (25.0 mL). D-mandelic acid (286.0 mg, 1.89 mmol, 0.5 eq) dissolved in acetonitrile (5 mL) was added dropwise to the reaction, and the addition was stirred at room temperature for 4 hours. After filtering, the filter cake was washed with acetonitrile (2.0 mL×1), and dried to obtain a white solid compound 3 crude product (0.48 g, yield: 37%). The ee value was determined to be 41.9% after derivatization of the solid.

重結晶:將化合物 3 粗品(0.48 g,  1.15 mmol)和乙腈(15.0 mL)加入反應瓶中。加畢室溫攪拌3小時。過濾,濾餅用乙腈(2.0 mL×1)洗滌,烘乾得到白色固體化合物 3 ( 0.22g,產率:45%)。取樣衍生測定ee值為73.00%。Recrystallization: Crude compound 3 (0.48 g, 1.15 mmol) and acetonitrile (15.0 mL) were added to the reaction flask. After the addition was completed, the mixture was stirred at room temperature for 3 hours. Filtration, the filter cake was washed with acetonitrile (2.0 mL×1), and dried to obtain white solid compound 3 (0.22 g, yield: 45%). The ee value determined by sampling derivation was 73.00%.

圖1是化合物1的X射線單晶繞射圖。FIG. 1 is an X-ray single crystal diffraction pattern of Compound 1. FIG.

圖2是化合物1的單晶中分子球棒模型。FIG. 2 is a single crystal molecular ball-and-stick model of compound 1. FIG.

圖3是化合物1的絕對構型。Figure 3 is the absolute configuration of compound 1.

Figure 108127452-A0101-11-0001-2
Figure 108127452-A0101-11-0001-2

Claims (20)

一種式(I)所示化合物的製備方法,其中,所述方法包括如下步骤:以式(IV)化合物為原料經過反應得到式(III)化合物,然後以式(III)化合物為原料進行反應製備得到式(I)化合物,
Figure 108127452-A0305-02-0060-17
A選自苯磺酸、對甲苯磺酸或甲磺酸;R1選自H或-C(=O)R11;R2選自第三丁基;R11選自甲基。
A method for preparing a compound represented by formula (I), wherein the method comprises the steps of: using the compound of formula (IV) as a raw material to obtain a compound of formula (III) through reaction, and then using the compound of formula (III) as a raw material for reaction preparation to obtain a compound of formula (I),
Figure 108127452-A0305-02-0060-17
A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid; R 1 is selected from H or -C(=O)R 11 ; R 2 is selected from tert-butyl group; R 11 is selected from methyl group.
根據請求項1所述的製備方法,其中,式(III)化合物的製備包括以式(IV)化合物和掌性酸為原料製備式(III)化合物;所述掌性酸選自式(XI)化合物、R-α-甲基苯乙酸、(-)-二乙醯基-L-酒石酸、L-天冬胺酸或者右旋奎寧酸;
Figure 108127452-A0305-02-0060-20
R1定義與請求項1相同。
The preparation method according to claim 1, wherein the preparation of the compound of the formula (III) comprises preparing the compound of the formula (III) by using the compound of the formula (IV) and a chiral acid as raw materials; the chiral acid is selected from the group of the formula (XI) compound, R-α-methylphenylacetic acid, (-)-diacetyl-L-tartaric acid, L-aspartic acid or d-quinic acid;
Figure 108127452-A0305-02-0060-20
R 1 definition is the same as claim item 1.
一種式(I)所示化合物的製備方法,其中,所述方法包括以式(IV)化合物為原料經過反應得到式(III)化合物,然後以式(III)化合物為原料先製備得到式(II)化合物,再以式(II)化合物為原料製備得到式(I)化合 物:
Figure 108127452-A0305-02-0061-21
A、R1、R2的定義與請求項1相同。
A method for preparing a compound represented by formula (I), wherein the method comprises using the compound of formula (IV) as a raw material to obtain a compound of formula (III) through reaction, and then using the compound of formula (III) as a raw material to first prepare a compound of formula (II) ) compound, and then use the compound of formula (II) as a raw material to prepare the compound of formula (I):
Figure 108127452-A0305-02-0061-21
The definitions of A, R 1 and R 2 are the same as in claim 1.
根據請求項3所述的製備方法,其中式(II)化合物與酸A在能與式(II)化合物相溶的溶劑中反應得到式(I)所示化合物,所述溶劑選自乙腈、二氯甲烷、乙醇、甲醇、乙酸異丙酯、水、甲苯、二氧六環或其組合,酸A與式(II)化合物的莫耳比為1.1:1~5:1,在70-90℃下反應。 The preparation method according to claim 3, wherein the compound of formula (II) is reacted with acid A in a solvent compatible with the compound of formula (II) to obtain the compound of formula (I), and the solvent is selected from acetonitrile, Methyl chloride, ethanol, methanol, isopropyl acetate, water, toluene, dioxane or a combination thereof, the molar ratio of acid A to the compound of formula (II) is 1.1:1~5:1, at 70-90°C next reaction. 根據請求項1或3所述的製備方法,其中,所述方法還包括式(III)化合物的精製方法,係將式(III)化合物在重結晶溶劑中重結晶;
Figure 108127452-A0305-02-0061-3
R1選自H或-C(=O)R11;R2選自第三丁基;R11選自甲基;式(III)化合物與重結晶溶劑的質量體積比為1:10-1:30,重結晶重複1-2次;其中所述重結晶溶劑為異丙醇和水。
The preparation method according to claim 1 or 3, wherein the method further comprises a method for purifying the compound of formula (III), which is to recrystallize the compound of formula (III) in a recrystallization solvent;
Figure 108127452-A0305-02-0061-3
R 1 is selected from H or -C(=O)R 11 ; R 2 is selected from tert-butyl group; R 11 is selected from methyl group; the mass volume ratio of the compound of formula (III) to the recrystallization solvent is 1:10-1 : 30, and the recrystallization was repeated 1-2 times; wherein the recrystallization solvent was isopropanol and water.
根據請求項1或2中任一項所述的製備方法,其中,所述方法還包括以式(V)化合物為原料製備式(IV)化合物的步驟,在催化劑/還原劑存 在下,在0-40℃下製備式(IV)化合物,所述催化劑/還原劑選自氯化鎳六水合物/硼氫化鈉或10%鈀碳/氫氣,
Figure 108127452-A0305-02-0062-22
R2定義與請求項1相同。
The preparation method according to any one of claim 1 or 2, wherein the method further comprises the step of preparing the compound of formula (IV) by using the compound of formula (V) as a raw material, in the presence of a catalyst/reducing agent, at 0 The compound of formula (IV) is prepared at -40°C, and the catalyst/reducing agent is selected from nickel chloride hexahydrate/sodium borohydride or 10% palladium on carbon/hydrogen,
Figure 108127452-A0305-02-0062-22
The definition of R 2 is the same as that of claim 1.
根據請求項6所述的製備方法,其中,所述方法還包括式(V)化合物的製備:包括以式(VI)化合物為原料製備式(V)化合物,在碳酸銫、第三丁醇鉀或者1,8-二氮雜二環十一碳-7-烯存在下,化合物(VI)與硝基甲烷發生反應,反應的溫度為60℃~回流,生成化合物(V);作為選擇,可以有溶劑存在,所述溶劑選自二甲亞碸或N,N-二甲基甲醯胺,
Figure 108127452-A0305-02-0062-25
R2定義與請求項1相同。
The preparation method according to claim 6, wherein the method further comprises the preparation of the compound of formula (V): comprising preparing the compound of formula (V) by using the compound of formula (VI) as a raw material, in cesium carbonate, potassium tertiary butoxide Or in the presence of 1,8-diazabicycloundec-7-ene, compound (VI) reacts with nitromethane, and the temperature of the reaction is 60° C. ~ reflux to generate compound (V); alternatively, you can In the presence of a solvent, the solvent is selected from dimethylsulfoxide or N,N-dimethylformamide,
Figure 108127452-A0305-02-0062-25
The definition of R 2 is the same as that of claim 1.
根據請求項7所述的製備方法,其中,所述方法還包括式(VI)化合物的製備:包括以式(VII)化合物為原料製備式(VI)化合物,在第三丁醇鉀、1,8-二氮雜二環十一碳-7-烯、二異丙基胺基鋰或者碳酸鉀或者氫化鋰存在下,式(VII)化合物與選自二甲氧基膦醯基乙酸第三丁酯、二乙氧基磷醯基乙酸第三丁酯、溴乙酸第三丁酯、氯乙酸第三丁酯或者乙醯乙酸第三丁酯中任意一種化合物發生反應生成式(VI)化合物,
Figure 108127452-A0305-02-0062-27
The preparation method according to claim 7, wherein the method further comprises the preparation of the compound of formula (VI): including preparing the compound of formula (VI) by using the compound of formula (VII) as a raw material, in the third potassium butoxide, 1, In the presence of 8-diazabicycloundec-7-ene, lithium diisopropylamide or potassium carbonate or lithium hydride, the compound of formula (VII) is combined with tert-butyl dimethoxyphosphinoacetic acid selected from the group consisting of ester, 3-butyl diethoxyphosphoryl acetate, 3-butyl bromoacetate, 3-butyl chloroacetate or 3-butyl acetoacetate react to generate the compound of formula (VI),
Figure 108127452-A0305-02-0062-27
一種式(VII)所示化合物的製備方法,其中,所述方法包括以式(VIII)化合物為原料製備式(VII)化合物,
Figure 108127452-A0305-02-0063-30
R3和R4和與其連接的碳原子共同形成環。
A preparation method of a compound represented by formula (VII), wherein the method comprises using the compound of formula (VIII) as a raw material to prepare the compound of formula (VII),
Figure 108127452-A0305-02-0063-30
R3 and R4 together with the carbon atom to which they are attached form a ring.
根據請求項9所述的製備方法,其中,所述方法包括如下步驟:(1)式(VIII)化合物在酸酐和2,4,6-三甲基吡啶、2,6-二甲基吡啶或吡啶存在下發生反應;(2)用無機鹼調節步驟(1)得到的反應液pH至8-11;(3)用無機酸將步驟(2)得到的混合物進行酸化處理得式(VII)化合物。 The preparation method according to claim 9, wherein the method comprises the following steps: (1) adding the compound of formula (VIII) in acid anhydride and 2,4,6-collidine, 2,6-lutidine or The reaction occurs in the presence of pyridine; (2) the pH of the reaction solution obtained in the step (1) is adjusted to 8-11 with an inorganic base; (3) the mixture obtained in the step (2) is acidified with an inorganic acid to obtain the compound of formula (VII) . 根據請求項9或10所述的製備方法,其中,所述方法還包括以式(IX)化合物與二級胺NH(R3)(R4)是在草醯氯、二氯亞碸、1-(3-二甲胺基丙基)-3-乙基碳二亞胺鹽酸鹽、1-羥基苯並三唑或者N,N'-羰基二咪唑存在下反應製備式(VIII)化合物,
Figure 108127452-A0305-02-0063-32
The preparation method according to claim 9 or 10, wherein the method further comprises that the compound of formula (IX) and the secondary amine NH(R 3 )(R 4 ) are in oxalic chloride, dichlorosulfite, 1 -(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 1-hydroxybenzotriazole or N,N'-carbonyldiimidazole is reacted to prepare the compound of formula (VIII) in the presence of,
Figure 108127452-A0305-02-0063-32
根據請求項11所述的製備方法,其中,所述方法還包括以式(X)化合物為原料製備式(IX)化合物的步驟,
Figure 108127452-A0305-02-0063-33
The preparation method according to claim 11, wherein the method further comprises the step of preparing the compound of formula (IX) by using the compound of formula (X) as a raw material,
Figure 108127452-A0305-02-0063-33
一種式(VII)所示的化合物的製備方法,其中,所述的方法包括以下步驟:
Figure 108127452-A0305-02-0064-4
(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(2)式(IX)化合物與二級胺NH(R3)(R4)反應生成式(VIII)化合物;(3)式(VIII)化合物反應生成式(VII)化合物;R3和R4和與其連接的碳原子共同形成環。
A preparation method of a compound shown in formula (VII), wherein the method comprises the following steps:
Figure 108127452-A0305-02-0064-4
(1) The compound of formula (X) reacts with cyclo()isopropyl malonate to form the compound of formula (IX); (2) the compound of formula (IX) reacts with secondary amine NH(R 3 )(R 4 ) to form The compound of formula (VIII); (3) the compound of formula (VIII) reacts to form the compound of formula (VII); R 3 and R 4 together with the carbon atom to which they are attached form a ring.
根據請求項13所述的製備方法,其中,所述方法包含如下步驟:(1)三乙胺甲酸鹽催化下,式(X)化合物與丙二酸環(亞)異丙酯反應,生成式(IX)化合物;(2)式(IX)化合物與二級胺NH(R3)(R4)反應生成式(VIII)化合物;(3)二氯甲烷或者1,2-二氯乙烷作溶劑,吡啶類的鹼存在下,式(VIII)與三氟甲烷磺酸酐反應後,無機鹼調節反應液pH至鹼性,再在酸性條件下製備得式(VII)化合物。 The preparation method according to claim 13, wherein the method comprises the following steps: (1) under the catalysis of triethylamine formate, the compound of formula (X) is reacted with cyclo()isopropyl malonate to generate compound of formula (IX); (2) compound of formula (IX) reacts with secondary amine NH(R 3 )(R 4 ) to generate compound of formula (VIII); (3) dichloromethane or 1,2-dichloroethane As a solvent, in the presence of a pyridine base, after the formula (VIII) is reacted with trifluoromethanesulfonic anhydride, the pH of the reaction solution is adjusted to alkaline with an inorganic base, and the compound of formula (VII) is prepared under acidic conditions. 根據請求項9或13所述的製備方法,其中,所述的製備方法包括式(VII)所示的化合物的精製方法:
Figure 108127452-A0305-02-0064-5
所述方法包括將式(VII)化合物與亞硫酸氫鈉常溫下加成成鹽,用乙酸乙酯、二氯甲烷或者甲基第三丁基醚萃取雜質,然後常溫下加鹽酸或硫酸或者氫氧化鈉反應結束後經後處理即得。
The preparation method according to claim 9 or 13, wherein the preparation method comprises a method for purifying the compound represented by formula (VII):
Figure 108127452-A0305-02-0064-5
The method includes adding the compound of formula (VII) and sodium bisulfite to salt at room temperature, extracting impurities with ethyl acetate, dichloromethane or methyl tertiary butyl ether, and then adding hydrochloric acid or sulfuric acid or hydrogen at room temperature. After the sodium oxide reaction is completed, it can be obtained by post-treatment.
一種式(I)所示的化合物的製備方法,其中,所述的方法包括以 下步驟:(1)以化合物(VII)為原料製備得到式(VI)化合物;(2)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(3)式(V)化合物發生還原反應得到(IV),再與式(XI)化合物反應得到式(III)化合物;(4)式(III)化合物通過反應得到式(II)化合物,再與酸A反應得到式(I)化合物;
Figure 108127452-A0305-02-0065-7
或者式(V)化合物發生還原反應後,經水解後,再與掌性酸式(XI)化合物反應得到式(XII)化合物,式(XII)化合物經水解,再與酸A反應生成式(I)化合物;
Figure 108127452-A0305-02-0065-8
A、R1、R2定義與請求項1相同。
A method for preparing a compound represented by formula (I), wherein the method comprises the following steps: (1) using compound (VII) as a raw material to prepare the compound of formula (VI); (2) compounding the compound of formula (VI) with Nitromethane reacts to generate the compound of formula (V); (3) the compound of formula (V) undergoes a reduction reaction to obtain (IV), and then reacts with the compound of formula (XI) to obtain the compound of formula (III); (4) formula (III) The compound obtains the compound of formula (II) by reacting, and then reacts with acid A to obtain the compound of formula (I);
Figure 108127452-A0305-02-0065-7
Or after the compound of formula (V) undergoes a reduction reaction, after hydrolysis, it reacts with the compound of chiral acid formula (XI) to obtain the compound of formula (XII), and the compound of formula (XII) is hydrolyzed and reacted with acid A to generate formula (I) ) compound;
Figure 108127452-A0305-02-0065-8
The definitions of A, R 1 and R 2 are the same as in claim 1.
根據請求項16所述的製備方法,其中,所述的方法包括以下步驟:(1)第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯存在下,化合物(VII)與二甲氧基膦醯基乙酸第三丁酯在10℃~40℃反應生成化合物(VI);(2)碳酸銫、第三丁醇鉀或1,8-二氮雜二環十一碳-7-烯存在下,化合物(VI) 與硝基甲烷在80℃~100℃發生反應生成化合物(V);(3)甲醇溶劑中,氯化鎳六水合物作催化劑,硼氫化鈉作還原劑,化合物(V)發生還原反應後,與掌性酸式(XI)化合物在0-40℃下反應得到式(III)化合物;(4)式(III)化合物水解得到式(II)化合物;(5)式(II)化合物與A反應得到式(I)化合物。 The preparation method according to claim 16, wherein the method comprises the following steps: (1) in the presence of potassium 3-butoxide or 1,8-diazabicycloundec-7-ene, compound ( VII) Reaction with tert-butyl dimethoxyphosphinoacetate at 10°C to 40°C to generate compound (VI); (2) cesium carbonate, potassium tert-butoxide or 1,8-diazabicyclodeca In the presence of monocarbon-7-ene, compound (VI) React with nitromethane at 80 ℃ ~ 100 ℃ to generate compound (V); (3) in methanol solvent, nickel chloride hexahydrate is used as catalyst, sodium borohydride is used as reducing agent, after compound (V) undergoes reduction reaction, Reaction with the chiral acid compound (XI) at 0-40°C to obtain the compound of formula (III); (4) the compound of formula (III) is hydrolyzed to obtain the compound of formula (II); (5) the compound of formula (II) reacts with A A compound of formula (I) is obtained. 一種式(I)所示的化合物的製備方法,其中,所述方法包括如下步驟:(1)式(X)化合物與丙二酸環(亞)異丙酯反應生成式(IX)化合物;(2)式(IX)化合物與二級胺NH(R3)(R4)發生反應生成式(VIII)化合物;(3)式(VIII)化合物發生反應生成式(VII)化合物;(4)以化合物(VII)為原料製備得到式(VI)化合物;(5)式(VI)化合物與硝基甲烷發生反應生成式(V)化合物;(6)式(V)化合物發生還原反應後,與掌性酸式(XI)化合物反應得到式(III)化合物;(7)式(III)化合物通過反應得到式(II)化合物,再與酸A反應生成式(I)化合物;
Figure 108127452-A0305-02-0066-10
Figure 108127452-A0305-02-0067-12
或者式(V)化合物發生還原反應後,經水解後,再與掌性酸式(XI)化合物反應得到式(XII)化合物,式(XII)化合物經水解,再與酸A反應生成式(I)化合物;
Figure 108127452-A0305-02-0067-13
A、R1、R2定義與請求項1相同;R3、R4定義與請求項9相同。
A preparation method of a compound represented by formula (I), wherein the method comprises the steps: (1) the compound of formula (X) reacts with cyclo()isopropyl malonate to generate the compound of formula (IX); ( 2) The compound of formula (IX) reacts with secondary amine NH(R 3 )(R 4 ) to form the compound of formula (VIII); (3) the compound of formula (VIII) reacts to form the compound of formula (VII); (4) to Compound (VII) is prepared as a raw material to obtain the compound of formula (VI); (5) the compound of formula (VI) reacts with nitromethane to generate the compound of formula (V); (6) after the compound of formula (V) undergoes a reduction reaction, it is reacted with palm The compound of formula (XI) is reacted to obtain the compound of formula (III); (7) the compound of formula (III) is reacted to obtain the compound of formula (II), which is then reacted with acid A to generate the compound of formula (I);
Figure 108127452-A0305-02-0066-10
Figure 108127452-A0305-02-0067-12
Or after the compound of formula (V) undergoes a reduction reaction, after hydrolysis, it reacts with the compound of chiral acid formula (XI) to obtain the compound of formula (XII), and the compound of formula (XII) is hydrolyzed and reacted with acid A to generate formula (I) ) compound;
Figure 108127452-A0305-02-0067-13
The definitions of A, R 1 and R 2 are the same as those of claim 1; the definitions of R 3 and R 4 are the same as those of claim 9.
一種式(III)、式(VIII)或式(XII)化合物及其異構體或藥學上可接受的鹽,
Figure 108127452-A0305-02-0067-14
R1選自H、羥基保護基或-C(=O)R11;R2選自羧基保護基或C1-6的烷基; R3和R4成環。
A compound of formula (III), formula (VIII) or formula (XII) and isomers or pharmaceutically acceptable salts thereof,
Figure 108127452-A0305-02-0067-14
R 1 is selected from H, a hydroxyl protecting group or -C(=O)R 11 ; R 2 is selected from a carboxyl protecting group or a C 1-6 alkyl group; R 3 and R 4 form a ring.
根據請求項1、3、16及18其中任一項所述的製備方法,其中,所述的製備方法包括式(I)所示的化合物的精製方法,其中,將式(I)化合物在N-甲基吡咯烷酮或二甲亞碸中加熱至溶解,加入乙酸異丙酯和/或水,攪拌析晶,過濾,減壓乾燥,即得:
Figure 108127452-A0305-02-0068-15
A選自苯磺酸、對甲苯磺酸或甲磺酸。
The preparation method according to any one of claims 1, 3, 16 and 18, wherein the preparation method comprises a method for purifying the compound represented by formula (I), wherein the compound of formula (I) is prepared in N - Heat to dissolve in methylpyrrolidone or dimethyl sulfite, add isopropyl acetate and/or water, stir for crystallization, filter, and dry under reduced pressure to obtain:
Figure 108127452-A0305-02-0068-15
A is selected from benzenesulfonic acid, p-toluenesulfonic acid or methanesulfonic acid.
TW108127452A 2018-08-09 2019-08-02 Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof TWI777079B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201810901235 2018-08-09
CN201810901235.6 2018-08-09
CN201810931821 2018-08-16
CN2018109318215 2018-08-16

Publications (2)

Publication Number Publication Date
TW202019872A TW202019872A (en) 2020-06-01
TWI777079B true TWI777079B (en) 2022-09-11

Family

ID=69414523

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108127452A TWI777079B (en) 2018-08-09 2019-08-02 Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof

Country Status (3)

Country Link
CN (1) CN112384493B (en)
TW (1) TWI777079B (en)
WO (1) WO2020029762A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4183771A4 (en) * 2020-07-20 2024-04-24 Sichuan Haisco Pharmaceutical Co Ltd Sustained-release pharmaceutical formulation of fused tricyclic gamma-amino acid derivative and preparation method therefor

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018050046A1 (en) * 2016-09-14 2018-03-22 四川海思科制药有限公司 Fused tricyclic γ-amino acid derivative, preparation method therefor, and medical use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2374595A (en) * 2001-04-19 2002-10-23 Warner Lambert Co Fused bicyclic or tricyclic amino acids
ES2531324T3 (en) * 2007-09-28 2015-03-13 Daiichi Sankyo Co Ltd Intermediate to produce a bicyclic gamma-amino acid derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018050046A1 (en) * 2016-09-14 2018-03-22 四川海思科制药有限公司 Fused tricyclic γ-amino acid derivative, preparation method therefor, and medical use thereof

Also Published As

Publication number Publication date
WO2020029762A1 (en) 2020-02-13
CN112384493B (en) 2023-06-06
CN112384493A (en) 2021-02-19
TW202019872A (en) 2020-06-01

Similar Documents

Publication Publication Date Title
JP6392436B2 (en) Process for the preparation of substituted 5-fluoro-1H-pyrazolopyridines
JP6872500B2 (en) How to make bribalacetam
JP2839344B2 (en) Method for producing cyclic amino acid and intermediate thereof
JPH0737460B2 (en) Pyranoindolizine derivative and method for producing the same
JP5894531B2 (en) Process for producing N-acylbiphenylalanine
WO2008062460A2 (en) Crystalline forms of pregabalin
JP7097467B2 (en) Bribalacetam intermediate, its manufacturing method and bribalacetam manufacturing method
TW201434851A (en) Process for the synthesis of E1 activating enzyme inhibitors
JP2003513974A (en) Method for producing imidazolidinone αv-integrin antagonist and intermediate for production
TW202002969A (en) Preparative process
TWI777079B (en) Preparation method of condensed tricyclic γ-amino acid derivatives and intermediates thereof
JP2012254982A (en) Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide hydrochloride and pharmaceutical composition containing the same
TW200815388A (en) Chromane and chromene derivatives and uses thereof
WO2014008639A1 (en) Method for preparing indacaterol
RU2729074C2 (en) Method of purifying a benzopyran derivative, its crystalline form and a method of producing a crystalline form
CN113423689A (en) Synthetic method for producing 1- ((3S,4R) -4- (2, 6-difluoro-4-methoxyphenyl) -2-oxopyrrolidin-3-yl) -3-phenylurea
JP2769058B2 (en) Preparation of cyclopropane derivatives
JP2020503338A (en) Method for preparing 6-aminoisoquinoline
KR100228328B1 (en) Process for preparing (2r)-methyl-4,4,4-trifluorobutyl amine or addition salt thereof with acid
KR101525296B1 (en) Lamivudine oxalate and preparation method thereof
CA2983788A1 (en) Method for producing dicarboxylic acid compound
JP2002535302A (en) Method for synthesizing compound of formula 1 and derivatives thereof
JP2002540101A (en) Synthesis of 3-amino-3-aryl propionate
JP2002371060A (en) Method for producing optically active aminopiperidine derivative
JP2000239237A (en) Crystal of optically active compound and its production

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent